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ABSTRACT 
Here, we present a series of fluorescent sensors based on the coumarin-3-
aldehyde scaffold intended to sense primary amine neurotransmitters. Discussed are 
the major design considerations, syntheses, initial UV/Vis and fluorescence titrations, 
and fluorescence microscopy studies in living cells. 
NeuroSensor 521 was developed as a turn-on molecular sensor for 
norepinephrine and dopamine. It was designed to bind with lower affinity in order to 
monitor dynamic changes in neurotransmitter concentrations and was validated in both 
live and fixed cells. The sensor selectively bound to norepinephrine- over epinephrine-
containing chromaffin cells producing prominent punctate fluorescence which is 
indicative of uptake into secretory granules. 
The NeuroSensor 521 model was used to produce 17 benzene- or thiophene-
based derivatives which differed only at the coumarin C4-substituent. The substituents 
ranged from very electron-donating to very electron-withdrawing and modulated the 
fluorescence of the fluorophore by changing the EHOMO levels and thereby the ability of 
various analytes to quench the fluorescence by photoinduced electron transfer (PET). A 
thorough computational analysis was bolstered by experimental fluorescence titrations. 
Lastly, a near-infrared (NIR) sensor was developed for the turn-on fluorescent 
sensing of serotonin, a known fluorescence-quenching analyte. The electron-rich sensor 
gave a fluorescence increase upon titration with serotonin and was shown to bind 
norepinephrine in chromaffin granules giving punctate fluorescence with an excitation 
of 633 nm and an emission of 710 nm. 
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CHAPTER ONE 
Introduction 
 
 
 
1.1 Fluorescent Sensors 
Fluorescent chemosensors are abiotic supramolecular devices or “hosts” that 
transform chemical information into measurable analytical signals via interactions with 
an analyte or “guest” (Figure 1-1).1 The intracellular detection of biologically important 
guests requires that fluorescent chemosensors exhibit selectivity, sensitivity, and 
solubility in aqueous environments.2   
 
 
Figure 1-1. Equilibrium of host-guest binding 
 
Fluorescent chemosensors bind to the analyte via non-covalent interactions (i.e. 
hydrophobic interactions, hydrogen bonding, metal coordination, electrostatic 
interactions, etc.) or reversible covalent bond formation.1, 3 Sensors possess a receptor, 
an optical reporter, and a signal transduction mechanism that communicates between 
the two (Figure 1-2).  
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Figure 1-2. Binding of an analyte guest to a chemosensor host 
 
Signal transduction mechanisms exclusive to fluorescence sensing include 
internal charge transfer (ICT), photoinduced electron transfer (PET), and Förster 
resonance energy transfer (FRET).4  PET and ICT, in particular, have been widely 
employed for amino acid, diamine, and amine chemosensors.3b 
  
1.2 Signal Transduction Mechanisms 
1.2.1 Internal Charge Transfer (ICT) 
 For internal charge transfer mechanisms, the receptor is directly conjugated to 
the pi system of the fluorophore. Electrons are transferred across the pi system from 
a donor group to an acceptor group. The energy of the ICT state is determined by 
the interaction of the solvent and/or the bound guest molecule with the 
donor/acceptor groups.3a Chemosensors using an ICT mechanism have been 
developed for numerous biological analytes including amines, saccharides, and 
metal ions (Figure 1-3).5,6,7,8 
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Figure 1-3. Sensors that use an ICT signal transduction mechanism 
 
1.2.2 Photoinduced Electron Transfer (PET) 
 Photoinduced electron transfer requires two non-conjugated components: a 
fluorophore and either an electron-donating group or an electron-withdrawing 
group.9 Two methods, acceptor-PET (a-PET) and donor-PET (d-PET), will be described 
later in detail. The literature is replete with chemosensors based on the PET 
transduction mechanism (Figure 1-4). 9-10 11 
 
 
Figure 1-4. Sensors that use a PET signal transduction mechanism 
4 
 
 1.2.3 Förster Resonance Energy Transfer (FRET) 
 FRET involves the transfer of energy from an excited donor fluorophore to an 
acceptor fluorophore in its ground state (Figure 1-5).12 For FRET to occur between a 
linked donor-acceptor pair, two criteria must be met: i) there must be significant 
spectral overlap between the fluorescence of the donor and the absorbance of the 
acceptor; ii) the pair must have an optimal distance of separation known as the 
“Förster distance” which is usually ~20-60 Ǻ and is defined as the distance at which 
the resonance energy transfer is 50% efficient.13 
 
 
Figure 1-5. FRET mechanism between a linked donor (D) and accepter (A) pair 
 
 FRET-based sensors have been used widely in biological studies, especially for 
the evaluation of protein folding and protein-protein interactions. The donor-
acceptor pairs can either be fluorescent proteins, or proteins tagged with 
fluorophores. Due to the distance-dependence of the FRET efficiency, both spatial 
and temporal information can be gleaned.12 Other experiments have included 
placing a conformationally-sensitive protein between a FRET pair. Experimental 
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results coupled with mathematical analysis can elucidate a signaling pathway’s 
negative feedback or biostability. 2, 14  
 
1.3 Neurotransmitters 
1.3.1 Background 
 Neuronal communication involves the transmission of chemical messengers or 
neurotransmitters from one neuron to the next across the synaptic cleft. The 
neurotransmitters packaged in high millimolar concentrations in intracellular 
compartments called vesicles.15,16 One commonality of many small molecule 
neurotransmitters is the presence of an amine functional group (Figure 1-6). The 
amine can be used as a recognition unit for molecular sensors.  
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Figure 1-6. Structures of various amine neurotransmitters 
 
The neurosecretory vesicles are acidic compared to the cytosol (pH ~5.5 and 7.2, 
respectively) which is important to the accumulation and retention of amine 
neurotransmitters.17,18,19,20 Most neurotransmitters are taken up into the vesicle 
against a proton or electrochemical gradient. Catecholamines, for example, utilize 
the vesicular monoamine transporter (VMAT) protein which exchanges protons in 
the vesicle for neurotransmitters (Figure 1-7). V-ATPase uses ATP to pump protons 
into the vesicular lumen. The protons accumulate and lower the pH within the 
vesicle. VMAT exchanges protons for catecholamines until a large gradient has been 
built against the cytosol. 
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Figure 1-7. Catecholamine uptake into secretory vesicles. V-ATPase uses ATP to 
pump protons into the vesicle while VMAT-2 exchanges the protons for 
catecholamines.  
 
 Synaptic small dense-core vesicles (SDCV) and large dense-core vesicles (LDCV or 
chromaffin granules) are the two morphologically distinct types of neurosecretory 
vesicles that mediate regulated secretion in neurons. Approximately 21,600 – 30,000 
LDCVs account for over 30% of the total chromaffin cell volume.21 In general, 
synaptic SDCVs primarily contain classical neurotransmitters, namely acetylcholine 
(ACh), γ-aminobutyric acid (GABA), and glutamate. In contrast, synaptic LDCVs 
primarily contain adenosine triphosphate (ATP), calcium, catecholamines, 
chromogranins, neuropeptide Y (NPY), and opioid peptides.  More specifically, the 
synaptic LDCVs within chromaffin cells of the adrenal medulla synthesize, sequester, 
and release the catecholamines norepinephrine (noradrenaline) and epinephrine 
(adrenaline) in high concentrations (0.5-1.0 M).15,16 
Dopamine β-hydroxylase (DBH) is a hallmark protein of noradrenergic cells that 
is responsible for the synthesis of norepinephrine (Figure 1-8).22  DBH is specifically 
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expressed in norandrenergic neurons and chromaffin cells of the adrenal medulla 
and catalyzes the oxidative hydroxylation of dopamine to form norepinephrine.  The 
enzyme phenylethanolamine N-methyltransferase (PNMT) is responsible for the 
subsequent conversion of norepinephrine to epinephrine.   
 
 
Figure 1-8. Synthetic pathway for catecholamine neurotransmitters 
 
PNMT is specifically expressed in chromaffin cells of the adrenal medulla and 
catalyzes the N-methylation of norepinephrine to form epinephrine. PNMT serves as 
the classical specific enzyme marker in enzyme assays to differentiate two putative 
subpopulations of chromaffin cells of the adrenal medulla: epinephrine- and 
norepinephrine-containing chromaffin cells. Traditionally, chromaffin cells 
expressing PNMT (termed andrenergic) primarily store and secrete epinephrine, 
whereas chromaffin cells lacking PNMT (termed norandrenergic) primarily store and 
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secrete norepinephrine. In addition to the traditional immunocytochemical PNMT 
enzymatic assay, the conventional protocol that entails the physical separation and 
isolation of chromaffin cells by centrifugation through density gradients permits the 
similar ascription to chromaffin cells phenotypes (epinephrine- and norepinephrine-
containing).23 Both the traditional PNMT enzymatic assay and the conventional 
physical isolation protocol and their associated mutually exclusive epinephrine- and 
norepinephrine-containing designation amongst chromaffin cells results in the 
misrepresentation of catecholamine stores in chromaffin cells.   
Cyclic voltammetry and liquid chromatography analyses distinguish three 
subpopulations of chromaffin cells based on epinephrine:norepinephrine ratios of 
total catecholamine stores.23,24,25,26 Chromaffin cells that store and release ≥80% 
epinephrine or norepinephrine are similarly designated as epinephrine- or 
norepinephrine-containing chromaffin cell subpopulations, respectively, and 
account for approximately 75% of all chromaffin cells.  The third subpopulation 
amongst chromaffin cells store and secrete both epinephrine and norepinephrine 
between 20% – 80% epinephrine:norepinephrine and accounts for approximately 
25% of all chromaffin cells. Therefore, all chromaffin cells traditionally obtained and 
designated as epinephrine-containing and norepinephrine-containing by means of 
conventional physical separation or traditional PNMT assay do contain variable 
amounts of their norepinephrine and epinephrine counterpart, respectively.   
The catecholamines serve as the principal neurotransmitters in the sympathetic 
nervous system and are critical to many physiological and cognitive 
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functions.15,16,27,28 Dopamine helps regulate attention, arousal, cognition, reward, 
and motor activity in the central nervous system. Abnormalities in dopaminergic 
biosynthesis and impaired neurotransmission are linked to many neurodegenerative 
and psychiatric disorders that include bipolar disorder, depression, Tourette’s 
syndrome, schizophrenia, and Parkinson’s disease.29,30,31 The gradual loss of 
dopamine producing neurons and concomitant loss of dopamine input to forebrain 
motor structures eventually leads to the classical debilitating motor symptoms such 
as resting tremor, muscular rigidity, and bradykinesia.32 Due to the high prevalence 
and devastating effects of these neurological disorders, a significant physical, 
emotional, and financial toll is placed on Americans today (Figure 1-9). 
 
 
Figure 1-9. Annual national economic burden of brain-related disorders as of 2007 
(in billions). Sources include: Neuroinsights, Office of Nat’l Drug Policy, Nat’l Institute 
of Diabetes, Alz Assoc., Duke University, American Psych. Association, Harvard, Nat’l 
Sleep Found., American Stroke Assoc., Prevent Blindness America, CDC, Journal of 
Clinical Psych, Epilepsy Foundation, Cost of Brain Disorders Europe. Obtained from 
http://scienceprogress.org/2007/10/brain-tech-is-here/. 
0 100 200 300 400
Addiction
Alzheimer's Disease
Obesity
Chronic Pain
Depressive Disorders
Attention Disorders
Sleep Disorders
Stroke
Vision
Hearing Loss
Anxiety
Schizophrenia
Epilepsy
Parkinson's Disease
Multiple Sclerosis
366 
148 
123 
95 
83 
77 
75 
57 
52 
50 
47 
33 
16 
10 
9 
$ (in billions) 
11 
 
Similarly, norepinephrine regulates many critical functions that include 
attention, memory, learning, emotion, and autonomic and cardiovascular function 
(e.g., heart rate and blood pressure).  In the periphery, norepinephrine increases 
heart rate, cardiac contractility, vascular tone, renin-angiotensin system activity, and 
renal sodium reabsorption.  Norepinephrine deficiency is characterized by severe 
deficits in autonomic regulation of cardiovascular function that leads to orthostatic 
hypotension and cardiovascular disease.  Extreme abnormalities of norepinephrine 
concentration levels lead to several diseases such as neuroblastoma, 
ganglioneuroblastoma, ganglioneuroma, paraganglioma, and diabetes mellitus 
ketoacidosis.33 Most importantly, dysregulated biosynthesis and neurotransmission 
of norepinephrine has been widely implicated in the pathophysiology of both 
Parkinson’s disease and attention-deficit hyperactivity disorder (ADHD).    
 
1.3.2 Conventional Detection Methods 
 Conventional methods for the detection of small molecule neurotransmitters 
include autofluorescence, histochemical staining, electrochemistry, and fluorescence 
tracers.  
Autofluorescence 
The catecholamines and serotonin contain aromatic groups which are observed 
in the UV/Vis spectral range. The respective absorption and emission bands for 
these analytes are at 290 nm and 340 nm for serotonin,34 280 nm and 317 nm for 
norepinephrine,35 280 nm and 317 nm epinephrine, and 279 nm and 315 nm for 
12 
 
dopamine.36 Basifying from pH 5 to 10 causes the absorbance to shift to the red and 
the fluorescence to decrease. The fluorescence quenching of catecholamines is 
attributed to their oxidation in alkaline solutions (Figure 1-10). 
 
 
 
 
Figure 1-10. Relationship between catecholamine oxidation potential and 
fluorescence quenching 
  
Histochemical Staining 
 Histochemistry involves the identification of the chemical constituents in cells 
and tissues and can be both qualitative and quantitative in nature.37 This technique 
typically involves isolation, fixation, and sectioning of a tissue followed by treatment 
with a stain or indicator and observation with microscopy. Using this method, it was 
determined that neurotransmitters and peptides were colocalized in rat and monkey 
brainstem tissue.38 It has also been used to monitor the localization of exogenous 
dopamine and serotonin in nematodes.39 
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Electrochemistry 
Electrochemical methods, which may include potentiometry, coulometry, or 
voltammetry, are also useful in neurochemistry for several reasons: i) action 
potentials are required for neuronal exocytosis, ii) many neurotransmitters can be 
detected oxidatively (e.g. dopamine, acetylcholine, norepinephrine, serotonin, 
glutamic acid, and GABA), iii) high temporal resolution enables evaluation of 
biological events oftentimes occurring on a millisecond timescale (e.g. synaptic 
firing), and iv) small electrodes can monitor very localized regions.40 Electrochemical 
methods have been used to measure dopamine content in individual synaptic 
vesicles (carbon-fiber microelectrodes (CFM)),41 assess the differences in the 
regulation of dopamine versus serotonin (CFM),42 and obtain measurements of both 
the membrane capacitance as well as the released transmitter (patch amperometry, 
Figure 1-11).43  
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Figure 1-11. Patch amperometry configuration 
 
 As mentioned previously, the oxidation of neurotransmitters at neutral pH 
enables facile detection via electrochemical methods. Catecholamines, in particular, 
oxidize to quinones and can give cyclized derivatives (Figure 1-12). The oxidized 
catecholamines tend to quench fluorescence which will be addressed in Chapter 3. 
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Figure 1-12. Oxidation and cyclization of dopamine. P.T. = proton transfer. 
 
Tracers 
 Tracers called “fluorescent false neurotransmitters” (FFNs) have been developed 
by the Sames group as neurotransmitter mimics.44 The sensors are taken up into the 
vesicle by the vesicle monoamine transporter, VMAT2. Using these sensors, they 
discovered that the number of vesicle fusion and firing events was dependent upon 
the frequency of stimulation applied.44a Application of electrical stimulus resulted in 
destaining of the striatal mouse brain slices. pH-sensitive versions were also 
developed and enabled quantification of vesicular pH, as well as visualization of 
enhanced background fluorescence upon stimulation indicating release of the 
vesicular contents into the synaptic cleft.44b, 44c 
  
1.3.3 Molecular Recognition Methods 
 Other methods for neurotransmitter detection using molecular recognition 
include bioorganic receptors, inclusion complexes, and boronic acid-based 
receptors. 
16 
 
Bioorganic receptors 
 There are several examples of bioorganic receptors for neurotransmitters in the 
literature.45,46,47,48,49,50 One example includes target-binding aptamers with 
appended pH-sensitive fluorophores. The fluorescence changes upon analyte-
binding due to the slightly altered pH of the microenvironment. 51 Another strategy 
has been to encapsulate target-binding enzymes in quantum dot (QD) hydrogels 
(Figure 1-13).52 When dopamine was added to one such QD hydrogel, it bound to 
the enzyme and caused a decrease in fluorescence due to dopamine oxidation to its 
quinone derivative. Pitfalls of this method include the limited use with aqueous 
media due to changes in gel porosity and reduced enzymatic activity upon 
dehydration of the gel. 
 
 
Figure 1-13. Dopamine sensing using enzyme-encapsulated QD hydrogels 
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Inclusion Complexes 
 Inclusion complexes, which may include calixarenes, cucurbiturils, cyclodextrins, 
porphyrins, and other macrocycles have also been developed for the detection of 
neurotransmitter analytes.53,54,55,56,57 
 Cucurbituril CB7 was developed to evaluate how the fluorescence properties of 
4’,6-diamidino-2-phenylindole (DAPI), a fluorescent dye, change as it binds inside the 
cavitand (Figure 1-14A).57 A competition study was conducted where CB7 was 
complexed with various analytes before DAPI is added. The DAPI displaces the 
alternate analytes which induces a fluorescence increase at 470 nm. This permits 
determination of binding constants which was shown to be very high for dopamine 
(1 x 105 M-1).  
 
 
Figure 1-14. Macrocyclic sensors for dopamine: a) Structure of CB7, and b) 
diazatetraester 1H-pyrazole crowns. 
  
 Other examples of macrocyclic binding to neurotransmitters are diazatetraester 
1H-pyrazole crowns for the detection of amphetamines and dopamine (Figure 1-
18 
 
14B).55 The R1-substituted and R2-substituted crowns bound to dopamine with 
affinities of 5.6 x 105 M-1 and 3.8 x 107 M-1, respectively. Molecular modeling 
calculations suggested stabilizing hydrogen bonding between the protonated 
ethylamine in dopamine and the esters and/or pyrazoles of the crown as well as 
between the catechol of dopamine and the carbonyl oxygens of the crown. A 
drawback of this work were the titration conditions (70:30 water/ethanol) which do 
not realistically exemplify the efficacy of detection in physiological environments. 
 
Boronic Acid Receptors 
 Neurotransmitters containing catechol moieties (e.g. dopamine, norepinephrine, 
and epinephrine) can be detected via the diol using boronic acid receptors. Yoon and 
coworkers, for example, developed a fluorescent chemosensor composed of 
imidazolium, pyrene, and boronic acid components (Figure 1-15).58 The boronic acid 
of the receptor reversibly forms a boronate with the diol in pH 7.4 buffer/MeCN 
(95:5) and quenches the fluorescence upon binding by over 6-fold. The excimer 
emission at 470 nm was dominant over the monomer peak at 355 nm. 
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Figure 1-15. a) Turn-off fluorescent pyrene-based boronic acid receptor for 
catechols58  
   
 Our group developed a ditopic sensor for dopamine that binds to the analyte 
amine and boronic acid.59 This sensor will be discussed further in Chapter 2, but it 
should be noted that it, too, gave a “turn-off” fluorescence response when bound to 
dopamine.   
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CHAPTER TWO 
Coumarin Aldehyde Sensors 
 
 
 
2.1 Coumarin Aldehyde with Tethered Boronic Acid 
Our group has labored toward creating fluorescent sensors for neurotransmitters 
based on the coumarin aldehyde scaffold.60,61 The sensor is composed of a coumarin 
fluorophore, an amine-binding aldehyde unit and an alkyl or aryl C4 substituent that 
either modulates binding by providing a secondary interaction with the analyte or 
modulates fluorescence by altering the electronic properties of the molecule (Figure 2-
1).  
 
 
Figure 2-1. Reversible binding of coumarin aldehyde sensors to primary amine analytes 
 
The sensor functions by an ICT signal transduction mechanism where an electron-
donating group (EDG) at the coumarin 7-position donates charge through the pi system 
to the electron acceptor at the 3-position. When the primary amine of the analyte binds 
to the aldehyde of the sensor, an iminium ion is formed which creates a better, 
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positively-charged acceptor. This induces a bathochromic shift in absorbance. By using 
an excitation wavelength corresponding to the bound sensor, a fluorescence increase 
can be observed in response to analyte addition. 
Compound 10 was first developed as a selective fluorescent sensor for dopamine 
and norepinephrine (Figure 2-2).59 The sensor aldehyde and boronic acid reversibly bind 
to the analyte amine and diol, respectively. Epinephrine is the only catecholamine 
neurotransmitter that cannot bind because it possesses a secondary amine which 
cannot form imines with aldehydes. 
 
 
Figure 2-2. Fluorescent molecular sensor for dopamine and norepinephrine. 
 
 The sensor demonstrated strong binding toward dopamine and norepinephrine 
(3400 M-1 and 6500 M-1, respectively) and weak binding toward other primary amine 
analytes that lack a catechol group like glutamic acid and lysine (6.8 M-1 and 4.0 M-1, 
respectively). As indicated previously, binding to the analyte induced a bathochromic 
shift in the absorbance by ~35 nm (Figure 2-3). The sensor, however, was quenched by 
all catecholamine analytes indicating that the bound species in each case was not 
emissive. For practical applications, the substantially high binding constants to 
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norepinephrine and dopamine prohibit the monitoring of dynamic changes in 
neurotransmitter concentrations as the sensor will be almost completely in its bound 
state. 
 
 
Figure 2-3. (A) UV/Vis and (B) fluorescence spectra of compound 8 (10 M) with 
dopamine in buffer (100 mM Na2S2O3, 50 mM HEPES, 20 mM NaCl, pH 7.0). ex = 484 
nm. em = 500 nm. Inset is the fit to a binding isotherm. 
 
2.2 NeuroSensor 521 
2.2.1 Design 
To afford, a turn-on fluorescence response to catecholamines, NeuroSensor 521 
(NS521) was developed (Figure 2-4). This sensor was altered to have only one 
binding site as opposed to sensor 10 which possessed two. Here, only the aldehyde 
group would associate with the analyte amines which would still induce a 
bathochromic shift upon analyte binding due to the formation of the iminium ion. 
Instead of a boronic acid group, a p-methoxyphenyl moiety was incorporated to 
modulate the fluorescence properties of the coumarin such that it would not be 
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quenched by the catechol group. It was anticipated that the lack of a boronic acid 
recognition unit would lower the affinity of NS521 for catecholamines relative to 
sensor 10, but given the extremely high concentration of catecholamines in the 
secretory vesicles, a lower binding constant was not a concern. In fact, it would 
permit a more reversible binding interaction so that both increases and decreases in 
neurotransmitter content could be observed. 
 
 
Figure 2-4. Equilibrium of norepinephrine binding to NS521 
 
Another key design parameter involves the net charges of the bound and 
unbound sensor. When unbound, NS521 is neutrally-charged and membrane-
permeable. However, upon binding, the positively-charged iminium ion that is 
created causes the bound species to become membrane-impermeable. This strategy 
allows the sensor to enter into the secretory vesicles, bind to the neurotransmitter, 
and then become trapped due to its cationic state (Figure 2-5). The fluorescence 
within the vesicle should increase as more of the bound sensor accumulates. 
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Figure 2-5. Mechanism of selective binding and accumulation of NS521 within 
norepinephrine-enriched secretory vesicles. (A) Step 1. NS521 enters secretory 
vesicular lumen. Step 2. NS521 does not bind to epinephrine (Epi) and does not 
fluoresce. Step 3. NS521 does not form a charged complex. Step 4. NS521 
translocates across vesicular membrane and exits vesicle. (B) Step 1. NS521 enters 
secretory vesicular lumen. Step 2. NS521 selectively labels norepinephrine (Nor) and 
fluoresces. Step 3. NS521-Nor complex is protonated. Step 4. Charged complex 
cannot translocate across vesicular membrane and accumulates. 
 
2.2.2 Synthesis 
 NS521 was synthesized in two steps from commercially available starting 
materials (Figure 2-6). Compound 11 was tosylated followed by a Suzuki coupling 
with p-methoxyphenylboronic acid (12) in a one-pot reaction to afford compound 
13. Treatment with the Vilsmeier reagent formylated the coumarin at the 3-position 
to produce NS521. 
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Figure 2-6. Synthesis of NS521 
 
2.2.3 Titrations 
NS521 was screened with various relevant amines via absorption and 
fluorescence spectroscopy. As observed with other sensors in this series,2 NS521 
binds to all primary amines via iminium ion formation, which produces a red shift in 
absorption from 448 to 488 nm (Figure 2-7). In fluorescence mode, exciting the 
sensor at 488 nm and adding norepinephrine produced a marked 5.3-fold increase in 
fluorescence. Table 2-1 summarizes binding and spectroscopic data for the 
interaction of NS521 and a number of relevant amines. As observed with other 
sensors in this series,2 all primary amines bind with low binding affinity and high 
fluorescence enhancements. Interestingly, catacholamines such as norepinephrine 
and dopamine have 10-fold higher binding constants than other alkyl amines such as 
glycine. As with other sensors in the class, NS521 does not interact with secondary 
amines such as epinephrine. 
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Figure 2-7.  (A) UV/Vis and (B) fluorescence spectra of NS521 (10 μM in 25 mM HEPES, 
50 mM Na2S2O3, pH 5.0) with norepinephrine (λex = 488 nm). Inset is the fit to a single-
site binding isotherm. 
 
The data in Table 2-1 indicates that the maximum fluorescence response of the 
catecholamines is lower than that of generic amines such as glutamate. The quantum 
yield for NS521 was determined both alone and bound to glutamate and 
norepinephrine. The 3-fold difference in the latter two quantum yields is due to the 
quenching nature of the catechol group, which can undergo photoinduced electron 
transfer (PET) to the coumarin fluorophore. Taken together, these data suggest that 
NS521 will bind more strongly to catecholamines in a cell, but with lower overall 
fluorescent enhancements.  
In a neuroendocrine cell, the concentration of catecholamines (0.5 − 1.0 M) in 
secretory vesicles is at least an order of magnitude greater than the concentration of 
other biogenic primary amines.18,19,20 Thus, the moderate selectivity of NS521 for 
catecholamines over other biogenic amines coupled with the relatively high 
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concentrations of catecholamines in secretory vesicles was expected to overcome the 
lower fluorescence response from the catecholamine. In addition, the unique spectral 
properties of NS521 allow for monitoring the unbound and bound states using 440 and 
488 nm excitation, respectively. 
 
Table 2-1. Binding constants (Ka) and spectroscopic parameters for the binding of 
NS521 to various analytes 
Amine Guest Ka (M
‑1)a Isat/I0
b Φfl
 c 
Epinephrine 0 nd nd 
Norepinephrine 78 5.4 0.0033 
Dopamine 112 3.0 nd 
Glutamate 10 7.8 0.0095 
Lysine 11 15.1 nd 
Glycine 8 11.1 nd 
None   0.0053 
a Binding constants (Ka) were measured by fluorescence spectroscopy, λex = 488 
nm, λem = 521 nm. Error in Ka values are ±10% based on triplicate titrations. 
bIsat  = 
fluorescence intensity at saturation taken from the theoretical fit to the binding 
isotherm. cQuantum yields (Φfl) were calculated using fluorescein as a 
fluorescence standard (Φfl = 0.850). nd = not determined. 
 
2.2.4 Cell Studies 
From the titration data, it appeared that NS521 could be used to selectively 
detect dopamine and norepinephrine over epinephrine. Thus, we chose to 
demonstrate the utility of our method through the selective labeling and direct 
visualization of norepinephrine in secretory vesicles to distinguish norepinephrine- 
from epinephrine-enriched populations of chromaffin cells. Chromaffin cells were 
separated into norepinephrine- and epinephrine-enriched fractions by 
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centrifugation on a Percoll gradient.62,63 Both populations were independently 
incubated with a 0.1 μM solution of NS521 at 37 °C for 30 min and then washed to 
remove excess sensor and plated. The cells were examined by confocal fluorescence 
microscopy using 488 nm excitation (Figure 2-8). 
 
 
Figure 2-8. Incubation of NS521 (0.1 M) with chromaffin cells. Epinephrine-
enriched cells: (A) ex = 488 nm and (C) ex = 440 nm. Norepinephrine-enriched cells: 
(B) ex = 488 nm and (D) ex = 440 nm. 
 
The norepinephrine-enriched cell population showed strong, punctate 
fluorescence compared to the epinephrine-enriched cell population, which only 
showed marginal fluorescence (Figure 2-8A,B). The punctate fluorescence pattern is 
consistent with secretory vesicles in chromaffin cells. These results indicate that the 
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sensor is able to enter the vesicle and bind to norepinephrine selectively over 
epinephrine, as anticipated. The low fluorescence response observed within the 
epinephrine-containing chromaffin cells was attributed to the binding of NS521 to 
the low concentration of norepinephrine present in these vesicles. Next, the cells 
were excited at 440 nm to selectively excite any potential unbound sensor, although 
some excitation of bound sensor is expected at this wavelength (Figure 2-8C,D). 
Weak fluorescence was observed in both cell populations, though again more in the 
norepinephrine-enriched population. These data suggest that little sensor remains in 
the epinephrine-enriched cell population. 
This result supports the notion that NS521 accumulates in vesicles, which is not 
surprising for a neutral compound that forms a charged complex upon interaction 
with the target analyte. The charged complex presumably cannot cross the vesicle 
membrane and thus becomes trapped (Figure 2-5).4 Thus, the higher fluorescence in 
the norepinephrine-containing cells is a result of the high concentration of primary 
catecholamine in the vesicles, which causes accumulation of the sensor in these 
vesicles. Lacking significant concentrations of primary catecholamines, the 
epinephrine-containing cells do not accumulate the sensor and show lower 
fluorescence. The overall low background fluorescence is remarkable given the 
rather promiscuous binding of NS521 to primary amines. Here the rather low affinity 
of the sensor for binding amines actually confers an advantage for selective labeling 
of high concentrations of primary amine analytes in secretory vesicles.  
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To further validate the selective labeling of norepinephrine-containing vesicles, 
we labeled fixed cells using an antibody against phenylethanolamine N-
methyltransferase (PNMT), an enzyme that converts norepinephrine to epinephrine. 
Antibody labeling was visualized with a Cy3-conjugated secondary antibody.23 It has 
been shown that epinephrine-enriched cell populations give the highest level of 
PNMT staining, while norepinephrine-enriched populations gave lower staining (ca. 
20% of that with epinephrine-enriched cells). For this experiment, three populations 
of chromaffin cells (norepinephrine-enriched, epinephrine-enriched, and mixed) 
were stained with NS521 and fixed in 4% paraformaldehyde. The fixed cells were 
stained with the anti-PNMT and secondary antibodies (Figure 2-9). The top row of 
Figure 2-9 shows that the NE-enriched cell population stains brightly with NS521 and 
weakly with the fluorescent antibody while the opposite is true for the EP-enriched 
cell population (second row). Indeed the mixed population of cells (third row, Figure 
2-9) contained cells with staining patterns consistent with both NE-enriched cells 
(circled in green) and EP-enriched cells (circled in red).  
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Figure 2-9. Immunohistochemical staining of chromaffin cells. All cells were stained 
with NS521 (1 μM), fixed (4% formaldehyde), and incubated with an anti-PNMT 
antibody followed by a Cy3-anti-rabbit antibody. Norepinephrine-enriched (NE) cells 
(A-C) visualized at (A) 525 nm, (B) 585 nm, and (C) bright field. Epinephrine-enriched 
(EP) cells (D-F) visualized at (D) 525 nm (E), 585 nm, and (F) bright field. Mixed cells 
(G-I) visualized at (G) 525 nm, (H) 585 nm, and (I) bright field. Cells circled in green 
indicate NE cells, and cells circled in red indicate EP cells. 
 
The fluorescence emission in the images shown in Figure 2-9 were quantified 
using ImageJ.64 EP-enriched cells show an increased anti-PNMT staining compared to 
NS521 (Figure 2-10A). Conversely, the NE-enriched cells showed an increased 
32 
 
staining by NS521 compared to the anti-PNMT. As expected, the mixed cell 
population contained cells which fell into both categories. The average fluorescence 
intensity ratio of 585 nm vs 525 for epinephrine-enriched cells was 6 times of that of 
norepinephrine-enriched cells (Figure 2-10B). 
 
 
Figure 2-10. Quantification of cell fluorescence from the cell populations from Figure 
2-9. (A) Fluorescence intensity at 585 nm plotted on the Y-axis and fluorescence 
intensity at 525 nm plotted on the x-axis. Each point represents an individual cell. EP 
cells fall above the blue line, and NE cells fall below the blue line. (B) The average 
ratio of fluorescence intensity at 585 nm vs 525 nm for NE and EP cells. 
 
In conclusion, NS521 was developed as a turn-on sensor for primary amines. It 
binds catecholamines such as norepinephrine more tightly than other biogenic 
amines such as glutamate, and it has no apparent affinity for secondary amines such 
as epinephrine. This selectivity was demonstrated in chromaffin cells where the 
norepinephrine-containing cells were stained preferentially over epinephrine-
containing cells under identical conditions. Furthermore, the fluorescence is not 
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affected by fixation. NS521 represents a convenient method to selectively stain 
norepinephrine and dopamine in neurosecretory vesicles. 
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CHAPTER THREE 
PET-Modulated Fluorescent Sensors 
 
 
 
 
3.1 a-PET vs. d-PET 
 Photoinduced electron transfer (PET) between a fluorophore and a pendant 
electron-donating or accepting group has been widely exploited in fluorescence 
sensing.9 Two schools exist: acceptor-PET (a-PET) and donor-PET (d-PET) (Figure 3-1). 
Acceptor-PET occurs when the excited fluorophore behaves as the electron-acceptor. 
An electron from the fluorophore is excited into a higher energy state. However, it is 
unable to fluoresce back down to the ground state because an electron from a donor is 
placed into the temporarily vacant ground state which means the excited electron must 
relax via some other non-radiative process.  
 By contrast, donor-PET occurs when the fluorophore acts as the electron-donor. 
Here, an electron from the fluorophore is excited into a higher energy state, but instead 
of fluorescing back down to its ground state, it transfers into the LUMO of a pendant 
acceptor group. Again, this prohibits fluorescence emission. 
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Figure 3-1. (A) Orthogonal pi-systems capable of PET. (B) Molecular orbitals describing 
acceptor-excited PET (a-PET) and donor-excited PET (d-PET). 
 
3.2 Previous Work 
Several research groups have exploited these electron transfer mechanisms in order 
to optimize the fluorescence output or to create fluorescence switches.65,66,67,68 For 
example, Nagano demonstrated the orthogonal pendant benzene moiety of fluorescein 
can quench fluorescence via a PET mechanism by developing xanthene-based 
TokyoGreens, fluorescein derivatives that lack or replace the ortho-substituted 
carboxylic acid group. 67   
The researchers designed and synthesized various derivatives of TokyoGreen where 
the electron density of the benzene moiety was tuned in a fine manner through the 
introduction of methyl and methoxy groups.  Furthermore, they demonstrated that the 
extent of PET quenching in TokyoGreens can be increased or decreased by altering the 
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electron density of the pendant aryl moiety (Figure 3-2).  Modifying the pendant aryl 
moiety of fluorescein did not alter the absorption and emission maxima relative to 
fluorescein, indicating the ground-state interaction between the benzene moiety and 
the xanthene moiety of the TokyoGreen derivatives was minimal and that the two 
moieties were conjugatively uncoupled.   
 
 
Figure 3-2. Selected TokyoGreen derivatives 
 
To describe these systems in a quantitative fashion, the rate of electron transfer (kET) 
between the excited state fluorophore (scaffold) and the pendant aryl moiety was 
determined from the free energy change for electron transfer (GET) using the Marcus 
equation. In turn, GET values were determined from the Rehm-Weller equation using 
experimentally-measured oxidation and reduction potentials of the platform 
components.66,69,70 The data could then be used to calculate the fluorescence quantum 
yields (Φfl) of the derivatives. Most importantly, Nagano demonstrated a direct 
relationship between the experimentally determined quantum yield and the calculated 
energy of the highest occupied molecular orbital (EHOMO) of the corresponding pendant 
aryl moiety. This relationship greatly facilitates the a priori determination of 
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fluorescence output. However, to be truly quantitative, it was necessary to have 
experimentally determined oxidation potential of the unsubstituted scaffolds 
(fluorophores). Thus, only the xanthene and BODIPY scaffolds have undergone 
quantitative evaluation. However, the method has been used for qualitative assessment 
of fluorescence properties based on platforms consisting of modified scaffolds.67, 68, 71,  
  Recently, we developed NS521 as a turn-on fluorescent sensor for the 
catecholamines norepinephrine and dopamine (Figure 3-3). NS521 derives from the 
coumarin-3-aldehyde scaffold, wherein the aldehyde group associates with the analyte 
primary amine group via reversible iminium ion formation.5, 72 The coumarin aldehyde 
fluoresces from an internal charge transfer (ICT) state. Formation of the iminium ion 
stabilizes the ICT state and shifts the wavelength of absorbance from 448 nm to 488 nm, 
allowing the bound and unbound forms of the sensor to be independently monitored by 
appropriate selection of the excitation wavelength.  
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Figure 3-3. Structures of select neurotransmitters. Structure of NS521 and formation of 
the iminium ion upon interaction with norepinephrine. 
 
In principle, the aldehyde group of NS521 can interact with any intracellular free 
primary amine. However, the low binding affinities of NS521 toward free primary 
amines (~10 M-1) coupled with the low concentration of intracellular free primary 
amines (5 mM) translates into extremely weak associations and thus, NS521 remains 
largely unassociated upon exposure to typical cells. However, specialized neurons 
sequester and package individual primary-amine neurotransmitters (e.g., glutamate, 
norepinephrine, dopamine, and serotonin) in secretory vesicles at extremely high 
concentrations (300 mM – 1 M) within an acidic environment (~pH 5).17,18,19,20,73,74,75  
We envisaged that the neutral NS521 would diffuse into the secretory vesicles of 
such specialized cells and only bind with the primary amine neurotransmitter due to the 
extremely high concentration of the bioanalyte. In turn, the resultant imine form of 
NS521 would become protonated to form a charged complex due to the acidic 
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environment within secretory vesicles and become membrane-impermeable (Figure 2-
4). As a result, the sensor would accumulate inside the secretory vesicles and allow for 
clear visualization of the neurotransmitter with low background. NS521 was initially 
validated in chromaffin cells and demonstrated selective detection of norepinephrine, 
allowing discrimination between norepinephrine- and epinephrine-enriched cell 
populations.61 
Since the fluorescent imaging of neurons, neurotransmitters, and events 
surrounding synaptic firing is an increasingly active area of research, the potential 
applications of such sensors are profuse. Fluorescent sensors would enable research in 
neuroscience by providing both the imaging of primary-amine neurotransmitters 
(especially for neurotransmitters such as dopamine that tend to quench fluorescence) 
and the continuous monitoring of primary-amine neurotransmitter trafficking. 
Therefore, we sought to establish a model by which sensors could be rationally designed 
for the purposes of neuroimaging. Since the NS521 platform consists of a fluorophore 
(scaffold) with a pendant orthogonal aromatic group, we designed various NS521 
analogues and applied Nagano’s method to this unique sensor system to evaluate the 
photophysical interaction between the platform components. 
Here, we report a series of benzene- and thiophene-substituted sensors based on 
the coumarin-3-aldehyde scaffold. The photophysical properties, binding affinities, and 
fluorescence responses toward glutamate, norepinephrine, and dopamine, were 
experimentally determined. DFT calculations provided the energy of the highest 
occupied molecular orbital (EHOMO) values of the pendant aryl substituents (calculated at 
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the B3LYP/6-31G(d) level of theory), which were fine-tuned through the introduction of 
various electron-withdrawing and -donating groups. In conjunction with the Marcus 
theory of electron transfer, oxidation and reduction potential values strictly derived 
from the calculated molecular orbital energy values of the fluorophore allowed for 
calculation of the fluorescence properties of the sensors. Good agreement between the 
calculated and experimentally determined fluorescence properties was found only in 
the case of the benzene-substituted sensors. 
 
3.3 NS521 Derivatives 
3.3.1 Design 
To systematically investigate the directly linked intramolecular PET in this 
system, a series of benzene- and thiophene-substituted derivatives based on the 
coumarin-3-aldehyde scaffold were prepared (Figure 3-4A).  Substituents on the C4 
aryl groups were chosen to cover a wide range of calculated EHOMO values (Figure 3-
4B). The primary difference between the two classes of aryl moieties is the dihedral 
angle of the pendant aryl moiety with respect to the plane of the coumarin aldehyde 
scaffold.  The thiophene class was determined to maintain a smaller dihedral angle 
(72.1°) compared to the benzene class (82.3°) based on geometry-optimized 
structures. For the purpose of discussion, it is noted that the only ortho-substituted 
derivative (1h) was determined to have a larger dihedral angle (89.3°). 
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Figure 3-4. Structures of the NS521 analogues used in this study: (A) General structures 
of Series 1 (benzene) and Series 2 (thiophene) derivatives accompanied by calculated 
bond angles; (B) Structures of the benzene-based (1a-l) and thiophene-based (2a-e) aryl 
moieties at the C4-position of the coumarin aldehyde scaffold. 
 
3.3.2 Synthesis 
 The sensors were prepared as shown in Figure 3-5. The synthesis of the benzene-
based sensors (1a-l) and the benzothiophene sensor (2e) was achieved through a 
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single Suzuki coupling reaction with compound 14 to provide the final products. The 
thiophene-based sensors (2a-d) were synthesized in two steps from compound 16, 
via tosylation and coupling followed by formylation under Vilsmeier conditions.  
 
 
Figure 3-5. Synthesis of (A) benzene- and (B) thiophene-substituted NS521 
derivatives. 
 
3.3.3 Titrations 
Spectroscopic Properties 
The sensors were titrated with glutamate as a representative amine and the 
absorption and fluorescence spectra recorded in buffer at pH 5 to mimic the acidic 
interior of the secretory vesicle. Representative spectral changes for sensors 1b and 
2b upon binding with analyte are shown in Figure 3-6. As observed with other 
sensors in this series, interaction with a primary amine produces a red shift in 
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absorption. For the series 1 sensors, the absorption of the bound species shifted 
from approximately 448 nm to 488 nm. Similarly, the emission maxima of the series 
1 sensors were red-shifted to approximately 520 nm upon binding, giving these 
sensors spectroscopic properties that conveniently match that of fluorescein. For 
the series 2 sensors, the absorbance shifts from approximately 467 nm to 502 nm 
upon interaction with glutamate and the emission shifts from approximately 522 to 
540 nm, which is 20 nm longer in wavelength than the absorbance values for the 
series 1 sensors. The absorbance maxima, fluorescence emission, and fluorescence 
quantum yield (Φfl) of the unbound and bound sensors were measured in buffer at 
pH 5.0 and tabulated in Tables 3-1 and 3-2 along with the EHOMO and ELUMO values 
calculated using standard methods. 
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Figure 3-6. (A) UV/Vis and (B) fluorescence spectra of sensor 1b (10 µM) with 
aliquots of 500 mM glutamate in buffer (25 mM HEPES, 50 mM Na2S2O3, pH = 5.0, 37 
°C). Excited at 488 nm. (C) UV/Vis and (D) fluorescence titration of sensor 2b (10 uM) 
with aliquots of 500 mM glutamate in buffer (25 mM HEPES, 50 mM Na2S2O3, pH = 
5.0, 37 °C). Excited at 515 nm. 
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Table 3-1. Photophysical properties of series 1 sensors 
 Absorbance
a
 Emission
a
 Quantum Yield
a,b
 Energy Values
c,d
 
 Unbound Bound
e
 Unbound
f
 Bound
e,g
 Unbound
f
 Bound
e,g
 EHOMO
x
 ELUMO
x
 
Benzene-Based Moiety λmax (nm) λmax (nm) λmax (nm) λmax (nm) pH 5.0 pH 5.0 hartrees hartrees 
h
4-Carbethoxy (1a) 456 493 534 534 0.0054 0.0100 -0.2561 -0.0422 
Phenyl (1b) 452 488 505 520 0.0072 0.0128 -0.2463 0.0036 
3-Methyl (1c) 452 488 505 522 0.0069 0.0102 -0.2354 -0.0054 
4-Methylthio (1d) 453 488 504 522 0.0067 0.0101 -0.2240 -0.0170 
h
4-Biphenyl (1e) 452 488 517 529 0.0085 0.0150 -0.2222 -0.0248 
3-Fluoro-4-methoxy (1f) 453 489 504 526 0.0063 0.0097 -0.2222 -0.0018 
(NS521) 4-Methoxy (1g) 452 488 505 521 0.0055 0.0095 -0.2151 0.0040 
Naphthalene (1h) 456 494 505 521 0.0078 0.0126 -0.2127 -0.0352 
3,4-Dimethoxy (1i) 452 488 503 522 0.0047 0.0094 -0.2109 0.0077 
4-Methoxy-3-methyl (1j) 452 488 502 522 0.0050 0.0093 -0.2106 0.0089 
3,4,5-Trimethoxy (1k) 452 489 505 522 0.0036 0.0090 -0.2085 0.0112 
4-Dimethylamino (1l) 451 488 505 521 0.0002 0.0009 -0.1844 0.0134 
a
Measured in buffer (1.0 µM sensor, 25 mM HEPES, 50 mM Na2S2O3, pH = 5.0, 37 °C). 
b
Calculated by using fluorescein 
as a fluorescence standard (Φfl = 0.85). 
c
Calculated EHOMO and ELUMO values of the aryl moiety. 
d
Data were calculated 
with DFT B3LYP/6-31G(d) using Gaussian 09W Rev. A.02. 
e
Bound sensor solutions contain 500 mM glutamate. 
f
Excited 
at 473 nm. 
g
Excited at 488 nm. 
h
Sensors 1a and 1e were adjusted to 5% and 30% DMSO, respectively. 
 
 
Table 3-2. Photophysical properties of series 2 sensors 
 Absorbance
a
 Emission
a
 Quantum Yield
a,b 
Energy Values
c,d
 
 Unbound Bound
e
 Unbound
f
 Bound
e,g
 Unbound
f
 Bound
e,g
 EHOMO
x
 ELUMO
x
 
Thiophene-Based Moiety λmax (nm) λmax (nm) λmax (nm) λmax (nm) pH 5.0 pH 5.0 hartrees hartrees 
2-Chlorothiophene (2a) 472 506 527 544 0.0019 0.0030 -0.2332 -0.0223 
Thiophene (2b) 462 502 522 539 0.0022 0.0038 -0.2328 -0.0076 
3-Methylthiophene (2c) 465 502 522 540 0.0028 0.0041 -0.2268 -0.0026 
2-Methylthiophene (2d) 467 502 521 540 0.0029 0.0042 -0.2216 -0.0045 
Benzothiophene (2e) 472 506 542 545 0.0039 0.0046 -0.2162 -0.0236 
a
Measured in buffer (5.0 µM sensor, 25 mM HEPES, 50 mM Na2S2O3, pH = 5.0, 37 °C). 
b
Calculated by using rhodamine 
B as a fluorescence standard (Φfl = 0.31). 
c
Calculated EHOMO and ELUMO values of the aryl moiety. 
d
Data were calculated 
with DFT B3LYP/6-31G(d) using Gaussian 09W Rev. A.02. 
e
Bound sensor solutions contain 500 mM glutamate. 
f
Excited 
at 473 nm. 
g
Excited at 515 nm. 
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Binding Affinities 
The association constants (Ka) of each sensor toward glutamate, norepinephrine 
and dopamine are listed in Tables 3-3 and 3-4 for series 1 and 2, respectively. The 
interaction between coumarin aldehydes and primary amines is a covalent reaction 
and, in principle, would be best represented as an equilibrium constant (Keq). 
However, because most supramolecular interactions are measured in terms of 
association constant, we have adopted that convention here for the sake of 
comparison and ease of use. Tables 3-3 and 3-4 also list maximum fluorescent 
enhancements (Isat/I0), which are the fluorescence intensities at saturation (as 
determined by the fit to a one-site binding isotherm) relative to the fluorescence 
intensities of the unbound sensors. These data give the maximum possible 
fluorescence response and are useful in comparing the spectroscopic properties of 
the fully bound sensor to the unbound state as well as to other sensors. 
Glutamate binds to all derivatives with the same relatively low affinity (5 – 10 M-
1). This result is consistent with other coumarin aldehyde sensors, which appear to 
bind all primary alkyl amines with similar low affinity.5,72 Surprisingly, the 
catecholamines bind roughly an order of magnitude better. Moreover, there is a 
clear trend toward better binding to sensors with more electron-rich aromatic 
groups in the C4-position. There appears to be subtle contact between the catechol 
group and the C4-aromatic, which increases with electron density on the C4-
aromatic residue. Interestingly, the thiophene-based sensors demonstrated slightly 
lower overall affinity than the benzene-based sensors and the electronic structure of 
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the thiophene does not appear to influence the binding constant of catecholamines. 
Although these binding constants are modest, they should suffice for cell imaging 
purposes because catecholamines are present at high concentrations (0.5 – 1 M) in 
secretory vesicles compared to the concentrations of typical amines present in a cell 
(5 mM) and would promote binding. Indeed, even glutamate is thought to be 
present in concentrations as high as 300 mM in vesicles of glutamatergic neurons.74 
Given that NS521 appears to accumulate in vesicles (vide supra), it is possible that 
some of the sensors described here could be used to image glutamate as well as 
catecholamines. 
 
Table 3-3. Association constants (Ka) for the binding of series 1 sensors to various 
analytesa 
 Amine Guest 
 Glutamate Norepinephrine Dopamine 
Benzene-Based Moiety Ka (M
-1
)
b
 Isat/I0
c
 Ka (M
-1
)
b
 Isat/I0
c
 Ka (M
-1
)
b
 Isat/I0
c
 
d
4-Carbethoxy (1a) 7.0 4.7 81.5 1.8 107.5 1.1 
Phenyl (1b) 9.4 10.5 68.7 6.6 68.1 3.2 
3-Methyl (1c) 9.2 10.0 68.4 6.6 74.1 3.2 
4-Methylthio (1d) 8.4 9.8 68.8 6.5 87.1 3.1 
d
4-Biphenyl (1e) 13.8 6.2 148.8 2.6 203.3 1.6 
3-Fluoro-4-methoxy (1f) 9.0 9.3 70.2 6.4 92.9 3.1 
 (NS521) 4-Methoxy (1g) 9.6 7.8 77.8 5.4 112.1 3.0 
Naphthalene (1h) 10.1 6.8 103.7 4.3 170.0 2.9 
3,4-Dimethoxy (1i) 10.2 6.6 107.2 4.1 177.5 2.7 
4-Methoxy-3-methyl (1j) 10.3 6.4 136.0 3.9 192.1 2.4 
3,4,5-Trimethoxy (1k) 10.3 5.6 159.1 2.6 205.1 1.6 
4-Dimethylamino (1l) 10.2 1.7 160.0 1.2 206.2 1.1 
a
Measured in buffer (1.0 µM sensor, 25 mM HEPES, 50 mM Na2S2O3, pH = 5.0, 37 °C). 
b
Ka 
measured by fluorescence spectroscopy. Excited at 488 nm. 
c
Isat = fluorescence intensity at 
saturation taken from the theoretical fit to a one-site binding isotherm. 
d
Sensors 1a and 1e 
were adjusted to 5% and 30% DMSO, respectively. 
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Table 3-4. Association constants (Ka) for the binding of the series 2 sensors to various 
analytesa 
 Amine Guest 
 Glutamate Norepinephrine Dopamine 
Thiophene-Based Moiety Ka (M
-1
)
b
 Isat/I0
c
 Ka (M
-1
)
b
 Isat/I0
c
 Ka (M
-1
)
b
 Isat/I0
c
 
2-Chlorothiophene (2a) 5.9 34 69.2 21 84.0 12 
(NS539) Thiophene (2b) 7.3 57 65.2 48 43.6 25 
3-Methylthiophene (2c) 7.4 51 63.6 38 51.1 23 
2-Methylthiophene (2d) 6.1 48 58.7 32 54.6 22 
Benzothiophene (2e) 5.2 30 49.6 17 49.3 9.5 
a
Measured in buffer (5.0 µM sensor, 25 mM HEPES, 50 mM Na2S2O3, pH = 5.0, 37 °C). 
b
Ka 
measured by fluorescence spectroscopy. Excited at 515 nm. 
c
Isat = fluorescence intensity at 
saturation taken from the theoretical fit to a one-site binding isotherm. 
 
Fluorescence Enhancements 
Upon analyte addition, the fluorescence enhancements for the series 1 sensors 
were very good: as high as an 11-fold increase for glutamate and a 6.6-fold increase 
for norepinephrine. As the absorbance maximum shifts to the red upon interaction 
with the analyte, selective excitation of the red wavelength produces a fluorescence 
increase upon binding. In addition, the fluorescence quantum yields of the bound 
sensors were higher than those for the unbound sensors. Thus, the observed 
fluorescence enhancements are due to the selective excitation wavelength used and 
an increase in fluorescence quantum yield upon binding. Indeed, better 
enhancements might be possible by judicious choice of excitation wavelength; 
however, we chose to use 488 nm because this wavelength is commonly available 
for imaging applications. The catecholamines can quench by PET, which is reflected 
in a lower fluorescence quantum yield for the dopamine- and norepinephrine-bound 
sensors compared to sensors bound to glutamate. However, useful enhancements 
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are seen even for those quenching analytes (Tables 3-3 and 3-4). It should be noted 
that sensors 1a and 1e required a DMSO cosolvent due to solubility issues, so the 
spectroscopic properties of these two sensors are not directly comparable to the 
others in this series. 
The fluorescence response of the series 2 sensors to the primary amine analytes 
was markedly higher than the fluorescence response of the series 1 sensors: as high 
as 57-fold for glutamate and 48-fold for norepinephrine. The difference in 
fluorescence response can be attributed to a lower initial fluorescence baseline. 
From Table 2, the quantum yields of the unbound thiophene derivatives are lower 
than those for the unbound benzene derivatives; however, the change in quantum 
yield between bound and unbound state were similar to the series 1 sensors. The 
major difference in the case of the series 2 sensors is that they were excited at 515 
nm to mimic a common laser line rather than exciting at the absorption maxima 
(~502 nm). At this higher excitation wavelength, the unbound derivative hardly 
absorbs, resulting in an overall low background that contributes to the very high 
fluorescence enhancements seen in Table 3-4. 
 
3.3.4 Computational Analysis 
Optimized models of the benzene-based sensors clearly indicate that the 
pendant aryl moiety is nearly perpendicular to the plane of the coumarin aldehyde 
scaffold (Figure 3-4A). The modeling results are supported by the fact that all of the 
benzene-based sensors (except 1h) have approximately the same absorbance and 
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emission maxima, indicating that the ground-state interaction between the pendant 
aryl moiety and the coumarin aldehyde scaffold was similar in all of them. The EHOMO 
and ELUMO values of the coumarin aldehyde scaffold were calculated to be -0.2109 
and -0.0805 hartrees, respectively (Figure 3-7). The calculated ELUMO values of the 
pendant aryl moiety of the benzene-based sensors (summarized in Table 1) are 
significantly higher than the calculated ELUMO values of the coumarin aldehyde 
fluorophore, indicating that a d-PET process is not operative. In contrast, the 
calculated EHOMO values of the pendant aryl moiety are in the same range as the 
calculated EHOMO value of the coumarin aldehyde fluorophore, suggesting an a-PET 
mechanism can modulate the fluorescence properties of the coumarin. Thus, the C4-
aryl moiety can be used to control the fluorescence properties of the coumarin 
aldehyde fluorophore. 
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Figure 3-7. Frontier orbital energy diagram of the PET process. (A) a-PET results in 
weak fluorescence. (B) Loss of a-PET quenching results in strong fluorescence. 
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This analysis also explains the differential fluorescence response of the sensors 
to the various analytes (Table 3-3). In all cases, dopamine and norepinephrine 
produce a lower fluorescence response than glutamate does. The calculated EHOMO 
values of the catecholamines (Table 3-5) indicate that these analytes should act as 
PET quenchers, with dopamine being a better PET quencher than norepinephrine. 
Indeed, this expectation was borne out from the observed fluorescence 
enhancements. Further, the calculated EHOMO value of serotonin is significantly 
higher than the EHOMO values for both catecholamines, indicating that serotonin 
should be a considerably better PET quencher of the coumarin aldehyde 
fluorophore. Indeed, serotonin completely quenches the fluorescence response of 
all sensor derivatives upon binding (data not shown).  
 
Table 3-5. Calculated EHOMO and ELUMO values for select neurotransmitters
a  
Neurotransmitter EHOMO ELUMO 
 
Serotonin 
-0.1890 -0.0022 
 
Dopamine 
-0.2025 -0.0028 
 
Norepinephrine 
-0.2078 -0.0082 
a
EHOMO and ELUMO values (hartrees) of the corresponding aryl 
moiety calculated with DFT B3LYP/6-31G(d) using Gaussian 
09W Rev. A.02. 
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PET Process in Series 1 Sensors 
As can be seen in Table 3-1, a wide range of fluorescence quantum yields was 
observed with the more electron rich pendant aryl moieties giving much stronger 
quenching. Interestingly, the quantum yields of the bound species are uniformly 
higher than the unbound species. The iminium ion formed upon binding has a lower 
calculated EHOMO value (-0.3373 hartrees) than the aldehyde (-0.2109 hartrees) and 
thus, would be subject to stronger quenching by the C4-aromatic group. However, 
this quenching effect is more than offset by the formation of the iminium ion which 
stabilizes and rigidifies the ITC state resulting in an overall increase in quantum yield 
upon binding.  
To evaluate the photophysical interaction between the pendant aryl moiety and 
the coumarin aldehyde scaffold, the relationship between the quantum yield for the 
unbound and bound series 1 sensors and the calculated EHOMO values of the 
corresponding benzene moiety was plotted and fit to the Marcus equation on the 
basis of the calculated EHOMO values (Figure 3-8). The calculated free energy change 
for electron transfer (GET) values, a prerequisite for fluorescence analysis in terms 
of the Marcus theory, were obtained as per the Rehm-Weller equation. In turn, the 
calculated free energy change for electron transfer (GET) values were derived, in 
part, from the oxidation and reduction potential values using an established linear 
correlation between the molecular orbital energy values (EHOMO and ELUMO) and the 
experimentally measured oxidation and reduction potential values.76 The 
experimentally determined quantum yields aligned with the fitted curves quite well, 
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indicating that the sensor platform fits the model of a directly linked donor-acceptor 
system. In the case of compound 1h having the 1-naphthyl group, both the unbound 
and bound quantum yields of 1h are higher than theory would predict. However, 
this difference is attributed to the greater rigidification of the fluorophore (vide 
infra) because the C4-naphthyl moiety is closer to 90° from the plane of the 
fluorophore (Figure 3-4A). 
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Figure 3-8. Comparison of photophysical properties of series 1 sensors. (A) 
Relationship between the calculated EHOMO values of the pendant aryl moiety and 
the fluorescence quantum yields for series 1 sensors (●) unbound and (○) bound 
with glutamate. The red box highlights naphthalene derivative. (B) Relationship 
between the calculated EHOMO values of the pendant aryl moiety and the 
fluorescence enhancement for series 1 sensors with (●) glutamate, (○) 
norepinephrine, and () dopamine. The shaded region identifies derivatives with 
selective fluorescent responses. The curves represent the best fit to the Marcus 
equation. 
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Because the absorbance maxima of the series 1 sensors were similar in both 
unbound and bound forms, the differences in fluorescent enhancement (Isat/I0) from 
Table 3-3 are due entirely to variations in quantum yield between the two forms. 
Thus, these maximum fluorescence changes were plotted versus the calculated 
EHOMO values (Figure 3-8B) and the same trends were observed as when plotting just 
the quantum yield.  Indeed, compound 1h, which was an outlier in Figure 6A, falls in 
line with the other derivatives in such a plot, indicating that the effect of the 
naphthyl group on the quantum yield was similar in both the bound and unbound 
states. Interestingly, the fluorescence enhancement for the series 1 sensors toward 
glutamate, norepinephrine, and dopamine followed a similar relationship, indicating 
that quenching analytes such as dopamine can quench all the sensors to the same 
degree.  
From this type of analysis, it is possible to identify sensors that would give 
selective turn-on fluorescent responses. For example, compounds in the green 
region of Figure 3-8B should give a good response to glutamate, but much weaker 
response to dopamine and norepinephrine. Of the sensors tested here, compound 
1k appears to be the best glutamate-selective sensor. Taken together, these results 
support the notion that an a-PET process modulates the fluorescence properties of 
the sensor platform and establishes a method for the rational design of selective 
sensors for primary amine neurotransmitters by variation of the C4-substituent. 
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Variation in Quantum Yields for the Series 2 Sensors 
Calculations indicated that the thiophene substituents have more π-overlap with 
the fluorophore than the phenyl groups of the series 1 sensors. This overlap causes 
the absorbance and emission of the series 2 sensors to be at longer wavelengths. 
Indeed, the trends indicated that the more electron-rich thiophenes display higher 
wavelengths of excitation and emission. However, the quantum yields of the 
thiophene derivatives were lower than that of most of the series 1 sensors. This low 
quantum yield effect has been observed in other directly linked donor-acceptor 
systems (platforms) and has sometimes been attributed to PET quenching from the 
thiophene.77  
The calculated EHOMO and ELUMO values of the series 2 sensors (Table 3-2) indicate 
that the a-PET mechanism is not operational in these derivatives. For the series 2 
sensors, the quantum yields trend upward as the group becomes more electron rich 
(Figure 3-9). It should be noted that for the chlorothiophene derivative (2a), it is 
possible that quenching due to the heavy atom effect of the chlorine may contribute 
to an anomalously low quantum yield for this sensor. Regardless, it is clear that PET 
quenching does not explain the low quantum yield of the thiophene derivatives. 
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Figure 3-9. Relationship between the calculated EHOMO values of the pendant aryl 
moiety and the fluorescence quantum yields for series 2 sensors (●) unbound and 
(○) bound with glutamate. 
 
If one compares the quantum yield of the naphthalene derivative (1h) to the 
other benzene derivatives (e.g., 1b) and the thiophene derivatives (e.g., 2b), the 
sensors in which the C4-group is more perpendicular and thereby, more rigid, have 
higher fluorescence quantum yields than those where the C4-group is more in plane 
with the coumarin aldehyde scaffold and thereby, less rigid (Figure 3-4A). These 
results indicate that twisting of the aryl-fluorophore bond in the excited state leads 
to non-radiative decay processes and lowers the quantum yield of the 
fluorophore.78,79 
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Summary of the Fluorescence Responses 
The fluorescence enhancements for the series 1 and 2 sensors upon binding to 
glutamate, norepinephrine, and dopamine are summarized in Figure 3-10 and Figure 
3-11, respectively. It should be noted that sensor 1g (NS521) does not have the 
highest fluorescence response of the series 1 sensors. However, we chose to utilize 
sensor 1g in our initial work because it struck a good balance between high 
fluorescence responses and good binding affinity toward norepinephrine and 
dopamine that would provide selective labeling and imaging in cellular studies.  
Overall, compared to the benzene-based series 1 sensors, the thiophene-based 
series 2 sensors provided only subtle differences in binding constants. However, the 
fluorescence enhancements for the thiophene-based series were considerably larger 
than the fluorescence enhancements for the benzene-based series. Of this series, 
sensor 2b had the highest fluorescence enhancements due to a high ratio of 
quantum yields between the unbound and bound sensor as well as high binding 
affinities toward the primary-amine analytes. Given the high fluorescence 
enhancements and red-shifted fluorescence properties observed for compound 2b 
(Table 3-3), we named this compound NeuroSensor 539 (NS539) and pursued cell 
imaging studies. 
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Figure 3-10. The fluorescence enhancements of series 1 derivatives toward 
glutamate (blue ), norepinephrine (green ), and dopamine (red ). 
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Figure 3-11. The fluorescence enhancements of series 2 derivatives toward 
glutamate (blue ), norepinephrine (green ), and dopamine (red ). 
 
3.3.5 Cell Studies 
Norepinephrine- and epinephrine-secreting chromaffin cells were isolated from 
bovine adrenal glands, separately incubated with NS539 (2b, 10 µM), and imaged 
using confocal fluorescence microscopy. The live cells were imaged at 458 nm which 
would excite any potential unbound sensor and at 514 nm which would excite the 
bound sensor.  
Excitation of the epinephrine cells at 514 nm provided marginal fluorescence 
response, indicating that the sensor is not binding to epinephrine (Figure 3-12B) as 
expected since epinephrine is a secondary-amine neurotransmitter (Figure 3-3). 
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Indeed, excitation at 458 nm gave no fluorescence, indicating that the unbound 
neutral sensor does not remain inside the cell (Figure 3-12A).  
However, the norepinephrine-enriched cells exhibited strong punctate 
fluorescence upon excitation at 514 nm (Figure 3-12E). Exciting the norepinephrine-
enriched cells at the wavelength associated with the unbound sensor (λex = 458 nm) 
similarly provided no measurable fluorescence response (Figure 3-12D). The results 
indicate that the NS539 only accumulates within secretory vesicles upon binding to 
norepinephrine, as previously seen with NS521.61 The ratio of the mean corrected 
total cell fluorescence intensity of norepinephrine- over epinephrine-enriched cells 
was approximately 27-fold (Figure 3-12G). These results validate NS539 as an 
excellent sensor for cellular imaging of primary-amine neurotransmitters with very 
low background. 
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Figure 3-12. Incubation of NS539 (2b, 10 µM) with chromaffin cells. Epinephrine-
enriched cells (A-C): (A) λex = 458 nm; (B) λex = 514 nm; (C) brightfield image. 
Norepinephrine-enriched cells (D-F): (D) λex = 458 nm; (E) λex = 514 nm; (F) 
brightfield image. Fluorescence was visualized using a 535-590 nm bandpass filter. 
(G) The mean corrected total cell fluorescence intensity for norepinephrine- and 
epinephrine-enriched (NE and EP, respectively) cells was 51.0 ± 2.6 and 1.86 ± 0.98 
respectively. Error bars represent standard deviation (n = 6). 
 
These data suggest that the coumarin-3-aldehyde scaffold and pendant aryl-
based moiety comprise a platform that constitutes a new directly linked donor-
acceptor system when the pendant aryl moiety is benzene-based, and 
thus, perpendicular to the plane of the fluorophore. The benzene-substituted series 
of sensors operates via an a-PET mechanism, which allows one to predict both the 
fluorescence quantum yields and the fluorescence responses toward primary-amine 
neurotransmitters based on DFT calculations.  
The results provide a rational design strategy for the development of turn-on 
fluorescent sensors for primary-amine neurotransmitters based on the coumarin-3-
aldehyde scaffold. The thiophene-substituted series of sensors did not follow the 
same trend based on PET quenching, indicating that the π-system of the 
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thiophene is more conjugated with the π-system of the fluorophore. However, due 
to favorable excitation/emission profiles, the thiophene sensors gave far superior 
fluorescence enhancements upon binding analytes.  
Based on these studies, NeuroSensor 539 was identified as a good candidate for 
biological imaging studies by demonstrating enhanced spectral and photophysical 
properties. The efficacy of NeuroSensor 539 was validated by selectively labeling 
and imaging norepinephrine in secretory vesicles of live chromaffin cells using 
longer excitation wavelengths that provided lower background. 
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CHAPTER FOUR 
Near-Infrared Sensing of Neurotransmitters 
 
 
 
4.1 Near-Infrared Sensing 
Near-infrared (NIR) bioimaging has become increasingly popular in recent 
years.80,81,82 The NIR region of the electromagnetic spectrum is typically considered 
between 650-900 nm and is preferred for biological imaging due to the excellent tissue 
penetration of long-wavelength light and low phototoxicity to cells (Figure 4-1).83 Also, 
the excitation and emission wavelengths of NIR sensors are far longer than those of 
autofluorescing molecules and tissues (e.g. flavins, nicotinamide, adenine dinucleotide, 
collagen, elastin, porphyrins, and etc.).84,85  
 
 
Figure 4-1. The electromagnetic spectrum 
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NIR molecular sensors have extended pi-systems and have been made from 
cyanines, BODIPYs, squaraines, and porphyrins, to name a few (Figure 4-2).81 For 
practical uses, the sensors need to have high quantum yields, large stokes shifts, 
modular syntheses for facile alteration, and high photostability. There is still a need for 
better molecular sensors that fit these criteria as there are only a few FDA-approved NIR 
dyes for in vivo bioimaging (e.g. indocyanine green, methylene blue).82,86 Moreover, 
there is now a strong movement to incorporate NIR indicators into therapeutic delivery 
systems to enable monitoring of drug release at target sites.87  
 
 
Figure 4-2. NIR dyes for bioimaging 
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We aim to develop a NIR sensor for serotonin. Serotonin contains an aromatic 
indole moiety and absorbs light at ~325 nm. Therefore, it is necessary to have a high-
wavelength absorbing and emitting fluorescent sensor in order to avoid background 
fluorescence from the analyte itself and to be more compatible with biological samples. 
It is important to note that fluorescence sensing of serotonin is difficult as the electron-
rich indole can easily quench fluorophores via photoinduced electron transfer (PET). 
  
4.2 Previous Work 
 The detection of serotonin is mainly achieved through analytical methods that 
include chromatographic and electrochemical techniques. Chromatographic techniques 
allow for selective detection of intracellular concentrations of serotonin, but require 
sample preparation unsuitable for preserving intact cells.88,89 Electrochemical 
techniques such as amperometry and cyclic voltammetry are non-destructive 
approaches allowing for selective detection of serotonin that relay quantitative and 
temporal information, but provide crude spatial information.90,91,92,93   
11C and 18F radioligands are developed as in vitro and in vivo noninvasive tracers 
based on positron emission tomography for imaging the serotonergic system in the 
human brain by targeting the 5-HT family of receptors (e.g., 5-HT1A) or the membrane-
bound human serotonin transporter (SERT) protein.94 The majority of radioligand tracers 
that are designed to interact with 5-HT receptors act as antagonists to label receptor 
populations that allow for quantification and imaging of receptor distribution. SERT-
specific positron emission tomography radioligands are designed as substrates for the 
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SERT protein in order to colocalize with serotonin within secretory vesicles and 
represent an optical approach for labeling secretory vesicles that contain serotonin 
through colocalization. As optical tracers, neither 5-HT receptor targeting nor SERT-
specific radioligands directly label serotonin.   
Fluorescence-based technologies remain a compelling approach to selectively 
detect and image serotonin.47, 95 In recent years, fluorescence-based approaches for 
monitoring serotonin interactions have included multi-photon excitation of intracellular 
serotonin,96 label-based fluorescent immunoassays,97,98 and fluorescent sensors such as 
amplifying fluorescent polymers (AFPs).99 However, the current fluorescence-based 
approaches either suffer from high background fluorescence, or do not represent 
practical approaches toward in vivo and ex vivo analyses because the approaches 
represent inapplicable bioorganic models or do not provide a fluorescence turn-on 
response due to the photophysical tendency of the electron-rich indoleamine moiety to 
quench the fluorescence response of the fluorophore through photoinduced electron 
transfer (PET).  
A water-soluble fluorescence-based molecular sensor permits a unified approach 
in the selective recognition and visualization of serotonin in vivo and in vitro analyses 
that limits interference with native neuronal functions. Moreover, a fluorescence-based 
turn-on molecular sensor possessing spectroscopic properties capable of fluorescence 
emission in the near infrared (NIR) spectral region (i.e., a wavelength emission greater 
than 600 nm) would be particularly advantageous by minimizing background from 
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biological analytes (i.e., riboflavin), reducing photodamage to biological samples, and 
allowing for greater tissue penentration. 
 
4.3 NeuroSensor 715 
4.3.1 Design 
 Here we report NeuroSensor 715 (NS715), a near-IR fluorescence-based turn-on 
molecular sensor for the selective recognition and sensing of serotonin based on a 
modified coumarin aldehyde scaffold with a design that capitalizes on the 
relationship between fluorescence response and DFT computational analyses and 
entails exclusively modifying the electron density of the fluorophore and 
corresponding EHOMO and ELUMO values. NS715 can be divided into two distinct 
moieties from the viewpoint of fluorescence: i) the modified coumarin aldehyde 
scaffold (fluorophore) and ii) the pendant thiophene moiety situated at the 4-
position of the coumarin core (C4-position) (Figure 4-3).   
 
 
Figure 4-3. Reversible covalent interaction between NeuroSensor 715 and serotonin 
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NS715 features an aldehyde recognition element at the 3-position of the 
coumarin core (C3-position) that associates with the analyte amine via iminium ion 
formation. The modified coumarin aldehyde scaffold derives from the electron-rich 
1,2,3,4-tetrahydroquinoxaline (THQ) framework. Ethyl groups situate the 1-and 4-
positions of the THQ framework. The rigid alkylated di-nitrogen species situated at 
the 6- and 7-positions of the coumarin core (C6- and C7-positions) were 
incorporated to modulate the fluorescence properties of the fluorophore such that 
the fluorescence response of NS715 would enhance upon interaction with serotonin. 
The fixed di-nitrogen species reinforce orbital alignment by restricting free rotation 
of the nitrogen atoms. A thiophene moiety is appended to the modified coumarin 
aldehyde scaffold at the C4-position and serves to provide a notable bathochromic 
shift in the absorption and emission profiles. 
 
4.3.2 Synthesis 
The synthesis of NS715 was accomplished in six steps from commercially 
available starting materials (Figure 4-4). Following literature precedent, 2-methoxy-
2-nitroaniline (22) was reduced using hydrogen gas and palladium on carbon to 
achieve the diaminobenzene.100 Treatment with glyoxal forms two imines creating 
compound 24 and reduction with sodium borohydride yields the tertiary amines. 
Friedel-Crafts acylation with 2-thiophenecarbonyl chloride acrylates the ring. 
Subsequent treatment with the ester-functionalized ylide gives a ,-unsaturated 
ester intermediate which undergoes intramolecular transesterification to produce 
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the coumarin scaffold. Formylation under Vilsmeier conditions yields the final 
product. 
 
 
Figure 4-4. Synthesis of Neurosensor 715 
 
4.3.3 Titrations 
 NeuroSensor 715 was screened with various relevant amines via absorption and 
fluorescence spectroscopy. As observed with other sensors in this series, 
NeuroSensor 715 binds to all primary amines via iminium ion formation, which 
produces a red shift in absorption from 500 to 546 nm (Figure 4-5A). In fluorescence 
mode, exciting the unbound NeuroSensor 715 at 559 nm provided fluorescence 
emission at 686 nm.  In fluorescence mode, exciting the bound complex at 559 nm 
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upon adding serotonin produced a marked 3.2-fold fluorescence enhancement at 
715 nm (Figure 4-5B). Table 4-1 summarizes binding and spectroscopic data for the 
interaction of NeuroSensor 715 with a number of relevant amines. Glutamate binds 
with a low binding affinity of 22.3 M-1 that provides a 1.7-fold fluorescence 
enhancement. The catecholamines norepinephrine and dopamine have on average 
6.0-fold higher binding constants compared to glutamate with a binding affinity of 
129 M-1 and 145 M-1 and a 2.0- and 2.6-fold fluorescence enhancement, 
respectively. Interestingly, serotonin has a 15-fold higher binding constant compared 
to glutamate with a binding affinity of 341 M-1 and 3.2-fold fluorescence 
enhancement. The bathochromic shift upon analyte binding was 46 nm, 37 nm, and 
30 nm for serotonin, the catecholamines, and glutamate, respectively. 
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Figure 4-5. (A) UV/Vis and (B) fluorescence spectra of NS715 (20 μM) in buffer (50 
mM Na2S2O3, 120 mM NaCl, pH 5.0) adding aliquots of 200 mM serotonin. Inset is 
the fit to a one-site binding isotherm. ex = 559 nm. em = 715 nm. 
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Table 4-1. Association constants (Ka) and spectroscopic parameters for the binding 
of NS715 to various analytes 
 
Amine Guest Ka (M
-1)a Isat/I0
b max,abs
c 
(nm) 
Serotonin 341 3.2 46 
Dopamine 145 2.6 37 
Norepinephrine 129 2.0 37 
Glutamate 22.3 1.7 30 
aKa measured by fluorescence spectroscopy, ex = 559 nm, em 
= 715 nm. Error in Ka values are 10% based on triplicate 
titrations. bIsat = fluorescence intensity at saturation taken from 
the theoretical fit to the binding isotherm. cBathochromic shift 
in absorbance upon saturating with analyte. 
 
4.3.4 Computational Analysis 
 The conventional DFT calculations using the hybrid exchange-correlation 
function B3LYP with the 6-31* basis set as implemented in Gaussian 09W were 
performed on the coumarin aldehyde scaffold of NeuroSensor 521 and the modified 
coumarin aldehyde scaffold of NeuroSensor 715. Several starting geometries were 
used for the geometry optimization to ensure that the optimized structure 
corresponded to a global minimum.   
Table 4-2 summarizes the computational calculations for the NS521 coumarin 
aldehyde scaffold, the NS715 THQ-derived modified coumarin aldehyde scaffold, 
and the indoleamine-based analyte, serotonin. The energy of the highest occupied 
molecular orbital (EHOMO) and lowest unoccupied molecular orbital (ELUMO) values of 
the NeuroSensor 521 coumarin aldehyde scaffold were obtained as -0.21087 and -
0.08046 hartrees, respectively, that corresponds to a calculated energy band gap of 
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0.13041 hartrees. The EHOMO and ELUMO values of the modified coumarin aldehyde 
scaffold of NeuroSensor 715 scaffold were obtained as -0.18982 and -0.07321 
hartrees, respectively, that corresponds to a calculated energy band gap of 0.11661 
hartrees. The EHOMO and ELUMO values of serotonin were obtained as -0.00385 and -
0.19282 hartrees, respectively. 
 
Table 4-2. DFT calculations of the EHOMO and ELUMO values for serotonin, NS521, and 
NS715 
 
Compound 
 
Serotonina 
 
NS521b 
 
NS715b 
EHOMO 
(hartrees) 
-0.19282 -0.21087 -0.18982 
ELUMO 
(hartrees) 
-0.00385 -0.08046 -0.07321 
aEHOMO and ELUMO values of the corresponding 5-hydroxyindole moiety; 
bEHOMO 
and ELUMO values of the corresponding coumarin aldehyde scaffold 
(fluorophore). 
 
4.3.5 Discussion 
NeuroSensor 715 
NeuroSensor 715 is a NIR fluorescence-based turn-on molecular sensor for the 
selective recognition and imaging of serotonin in neurosecretory vesicles.  
NeuroSensor 715 is envisaged to integrate with a tailored approach to comprise a 
method for the selective labeling and visualization of serotonin in live and fixed cells 
analogous to the method utilizing the NeuroSensor 521 predecessor for selective 
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recognition of catecholamine-based neurotransmitters norepinephrine and 
dopamine.61 The method entails utilizing NeuroSensor 715 to exploit the high 
concentration of serotonin and acidic environment within secretory vesicles through 
the formation of a charged complex that prevents translocation across the vesicle 
membrane and accumulates within secretory vesicles. 
NeuroSensor 715 features an aldehyde group that associates with the analyte 
amine via iminium ion formation and features a pendant thiophene moiety at the 4-
position of a modified coumarin aldehyde scaffold derived from the electron-rich 
THQ framework.  The modified coumarin aldehyde scaffold and pendant thiophene 
moiety are key design parameters that i) confer a fluorescence turn-on response 
upon binding to serotonin, and ii) impart spectroscopic properties to NeuroSensor 
715 that allow for direct monitoring of the unbound and bound states using a 
conventional confocal microscope equipped with the standard 488 nm and 559 nm 
lasers, respectively. NeuroSensor 715 exhibits an unprecedented 3.2-fold 
fluorescence enhancement at 715 nm in the NIR spectral region with a binding 
affinity of 341 M-1 in in vitro analyses.  NeuroSensor 715 binds to serotonin with a 
15-fold and 6.0-fold higher binding constant compared and to typical primary 
amines and catecholamines such as glutamate and norepinephrine. 
 
Spectral Characteristics 
NeuroSensor 715 incorporates a pendant thiophene moiety and fused alkylated 
di-nitrogen species to that derives from the THQ framework to constitute a modified 
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coumarin aldehyde moiety and provides pronounced spectroscopic and 
photophysical properties. Table 4-3 provides a comparison of the spectral 
characteristics between a benzene-based NeuroSensor 521 derivative, a thiophene-
based NeuroSensor 521 derivative, and NeuroSensor 715, and highlights the effect 
of both the incorporation of the thiophene moiety at the C4-position and the 
electron-rich THQ framework of the coumarin core that situates electron-donating 
nitrogen substituents at the C6- and C7-positions. 
Replacing the pendant benzene moiety with a thiophene moiety on the 
coumarin aldehyde scaffold of the NeuroSensor 521 platform affords a reasonable 
bathochromic shift of 10 nm and 17 nm in absorbance and fluorescence emission, 
respectively, with a maximum absorbance and fluorescence emission at 462 nm and 
522 nm, respectively. In doing so, both the unbound and bound Stokes shift 
increases 53 nm and 32 nm, respectively, for the benzene-based NeuroSensor 521 
derivative to the unbound and bound Stokes shift of 60 nm and 37 nm, respectively 
for the thiophene-based NeuroSensor 521 derivative.   
Modify the coumarin aldehyde scaffold by fixing electron-donating nitrogen 
species at the C6- and C7-positions results in a drastic bathochromic shift in the 
absorption and emission profiles. The pendant thiophene and THQ-derived modified 
coumarin aldehyde scaffold afford a noteworthy bathochromic in both the 
absorption and fluorescence properties with a 500 nm and 546 nm maximum 
absorbance and a 686 nm and 715 nm maximum fluorescence emission for the 
unbound and bound complex, respectively. The Stokes shift of both the unbound 
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and bound complex of NeuroSensor 715 increases over 125 nm compared to the 
thiophene-based NeuroSensor 521 derivative to 186 nm and 169 nm, respectively. 
 
Table 4-3. Comparison of spectroscopic properties sensors based on the coumarin-3-
aldehyde scaffold 
 
 NeuroSensor 521 Derivatives NeuroSensor 715 
Spectral Properties 
 
  
abs/em (nm)
a 452/505 462/522 500/686 
abs/em (nm)
b 488/520 502/539 546/715 
Stokes shift (nm)a  53 60 186 
Stokes shift (nm)b 32 37 169 
aSpectroscopic properties of the unbound sensor; bSpectroscopic properties of 
the sensor saturated with primary amine analyte. 
 
Computational Analysis 
The electron-rich nature of serotonin is known to quench the fluorescence 
response of fluorescent sensors upon interaction with serotonin through a 
photoinduced electron transfer (PET) mechanism. Until the development of 
NeuroSensor 715, no fluorescence-based approaches were capable of producing a 
turn-on fluorescence response upon interaction with serotonin. Indeed, the 5-
hydroxyindoleamine moiety of serotonin strongly quenched all benzene- and 
thiophene-based NeuroSensor 521 derivatives. Our working hypothesis was that the 
EHOMO value of the 5-hydroxyindoleamine moiety was significantly higher than the 
EHOMO value of the NeuroSensor 521-based coumarin aldehyde scaffold and 
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quenched the fluorescence of the coumarin aldehyde scaffold (fluorophore) through 
an acceptor-excited PET (a-PET) process (Figure 4-6A).   
Density function theory (DFT) computational analyses at the B3LYP/6-31G(d) 
level of theory guided the design of NeuroSensor 715 with calculations of the EHOMO 
and ELUMO values of the THQ-derived modified coumarin aldehyde scaffold that 
support the incorporation of a rigid alkylated di-nitrogen species by concomitantly 
raising the EHOMO and lowering the energy band gap between the ground and excited 
singlet states of the fluorophore such that the fluorescence of NeuroSensor 715 
enhances upon interaction with serotonin in the NIR spectral region.  As depicted in 
Figure 4-6A, the calculated EHOMO value of -0.19282 hartrees for the 5-
hydroxyindoleamine moiety is considerably higher than the calculated EHOMO value 
of -0.21087 hartrees for the NeuroSensor 521-based coumarin aldehyde scaffold and 
thus, permits serotonin to quench the fluorescence of the fluorophore upon 
excitation.   
The calculations support the notion that serotonin quenches the fluorophore of 
the NeuroSensor 521-based derivatives through an acceptor-excited PET (a-PET) 
process.  As depicted in Figure 4-6B, the calculated EHOMO value of -0.18982 hartrees 
for the THQ-derived modified coumarin aldehyde scaffold elevates the ground state 
of the fluorophore of NeuroSensor 715 above the calculated EHOMO value of the 5-
hydroxyindoleamine due to situating electron-donating nitrogen species at the C6- 
and C7-positions of the modified coumarin aldehyde scaffold that thereby, affords 
an increase in fluorescence response by preventing the 5-hydroxyindoleamine 
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moiety from donating an electron from a lower energy lying orbital into the 
fluorophore of NS715 through an a-PET process.  
In short, the 5-hydroxyindoleamine moiety cannot quench the fluorescence of 
the NS715 fluorophore due to the fluorophore exhibiting a higher ground state 
energy compared to the 5-hydroxyindoleamine moiety. Moreover, the pronounced 
photophysical properties NeuroSensor 715 demonstrates is consistent with the 
calculated energy band gap of 0.11661 hartrees between the EHOMO and ELUMO values 
of the THQ-derived modified coumarin aldehyde. That is, the smaller calculated 
energy band gap for NeuroSensor 715 compared to the calculated energy band gap 
of 0.13041 hartrees for NeuroSensor 521 coumarin aldehyde scaffold coincide with 
fluorescence emission of longer wavelength light at 715 nm in the NIR spectral 
region. 
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Figure 4-6. Frontier orbital energy diagram and schematic representation of 
acceptor-excited PET (a-PET) mechanism. Schematic representation of the (A) EHOMO 
value of the corresponding coumarin aldehyde scaffold of derivatives of the NS521 
platform, and (B) EHOMO of the corresponding modified coumarin aldehyde scaffold 
of NS715, both in relation to the EHOMO of the corresponding 5-hydroxyindole moiety 
of serotonin.   
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4.3.6 Cell Studies 
 Cellular studies were conducted by incubating NS715 with live chromaffin cells 
that were separated into norepinephrine-enriched (NE) and epinephrine-enriched 
(EP) subpopulations. Based on our work with NS521, we expected the NE cells to 
fluoresce, as norepinephrine has a primary amine and could interact with the 
aldehyde of NS715.61 Epinephrine, on the other hand, has a secondary amine and 
therefore, should not interact with the sensor or provide a fluorescence response. A 
458 nm laser was used to visualize any unbound sensors and a 633 nm laser was 
used to image the bound complex (Figure 4-7). 
 
 
Figure 4-7. Incubation of NS715 (10 M) with chromaffin cells. Epinephrine-enriched 
cells (A-C): (A) λex = 458 nm; (B) λex = 633 nm; (C) brightfield image. Norepinephrine-
enriched cells (D-F): (D) λex = 458 nm; (E) λex = 633 nm; (F) brightfield image. 
Fluorescence was visualized using a 650-710 nm bandpass filter. (G) The mean 
corrected total cell fluorescence intensity for norepinephrine- and epinephrine-
enriched (NE and EP, respectively) cells was 42.77  0.91 and 2.52  0.12 
respectively. Error bars represent standard deviation (n = 12). 
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 The NE cells showed strong punctate fluorescence and had a mean corrected 
total cell fluorescence intensity that was 17-fold greater than the EP cells which 
were sparsely fluorescent. These results indicate that i) NS715 can permeate the 
vesicular membrane of secretory vesicles, and ii) NS715 is selective for primary-
amine neurotransmitters over secondary amines. Excitation of the cells at 458 nm 
would have visualized any unbound sensor molecules, but the lack of fluorescence 
signal indicates that nearly all NS715 molecules were in the bound state.  
Future studies would include testing this sensor in serotonergic neurons and/or 
tissues to evaluate the in vivo response to the highly concentrated populations of 
intravesicular serotonin.   
 
4.3.7 Conclusions 
 NeuroSensor 715 was developed as a NIR fluorescence-based turn-on molecular 
sensor for the selective labeling and visualization of serotonin in synaptic vesicles of 
neuronal cells. DFT computational analyses at the B3LYP/6-31G(d) level of theory 
aided in the design and inclusion of the electron-rich THQ framework into the 
coumarin core to provide the modified coumarin aldehyde scaffold constituting 
NeuroSensor 715. The rigid, electron-donating di-nitrogen species at the C6- and C7-
positions of the coumarin core reinforce orbital alignment by restricting free 
rotation of the nitrogen atoms and impart pronounced spectroscopic and 
photophysical properties by simultaneously raising the calculated EHOMO value above 
the EHOMO value of the 5-hydroxyindoleamine moiety of serotonin to allow for a 3.2-
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fold fluorescence enhancement at 715 nm in the NIR spectral region with a binding 
affinity of 341 M-1 in in vitro analyses.  NeuroSensor 715 represents a convenient 
molecular sensor designed for integration with a tailored approached and proven 
method for the selective labeling and visualization of serotonin in live and fixed 
neuronal cells.  
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APPENDIX 
Experimental Procedures and Characterization Data 
 
 
 
Part I. General Information 
All reagents and solvents were purchased from commercial sources (Sigma 
Aldrich, Acros Organic, Fisher Scientific, Alfa Aesar, TCI America, or Combi-Blocks) and 
used without further purification unless stated otherwise. Anhydrous dichloromethane, 
acetonitrile, and triethylamine were obtained by distillation from CaH2. Anhydrous THF 
and toluene were obtained by distillation from sodium metal and benzophenone. All 
reactions were conducted using oven or flame dried glassware and under N2 
atmosphere unless stated otherwise. Flash column chromatography was carried by 
using 32-63 μm silica gel.  
NMR spectra were obtained by a Bruker ARX-250 MHz, DRX-300 MHz, or DRX-
500 MHz in CDCl3 or DMSO-d6 using tetramethylsilane (TMS) as a reference. IR spectra 
were obtained from Nicolet FT-IR spectrometers. High resolution mass spectra (HRMS) 
were obtained from a Bruker Apex-Qe FTMS at Old Dominion University in Norfolk, VA. 
 
Part II. Spectroscopic Studies 
UV-Visible spectra were obtained by a Varian Cary-1E UV-Visible spectrometer. 
Fluorescence spectra were obtained by a Shimadzu RF-5301 PC spectrofluorometer. 
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Titrations were performed by using bis-tris propane or HEPES buffer with NaCl or 
Na2S2O3 added unless otherwise stated. Absorbance and fluorescence spectra were 
processed using SigmaPlot™ 12.3 and best-fit lines fit using GraphPad Prism 6.01. 
 
Part III. Binding Constant Determination 
 
For all host (H) –guest (G) binding titrations, data was fit to a 1:1 binding isotherm: 
  
 
       (eq.1) 
 
f  = fractional occupancy; Ht = concentration of total sensor; Gt = concentration of total 
analyte; [G] = concentration of free analyte; [HG] = concentration of bound host-guest 
complex; Kd = dissociation constant 
 
There is an inverse relationship between the binding constant (Ka) and dissociation 
constant (Kd): 
           (eq. 2) 
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Given that the concentration of total analyte is far greater than the dissociation 
constant, Gt is considered equal to [G]. Equation 3 can be used to estimate the Kd: 
 
         (eq. 3) 
 
For fluorescence titrations, the intensity difference upon analyte addition can be used 
with the concentration of free analyte and the theoretical fluorescence maximum to 
solve for the dissociation constant using Equation 4. 
 
                    (eq. 4) 
Bmax = the theoretical fluorescence maximum when the host is saturated with guest 
 
Part IV. Protocol for Cellular Assays 
 
Cell Preparations: 
1. Separate cells: Bovine chromaffin cells were obtained from Alice (Xin Liu, Gillis 
Group, Dalton Cardiovascular Research Center). The cells were pre-separated 
into epinephrine and norepinephrine-containing populations using a Percoll 
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gradient.62 Each cell type was suspended in ~3 mL chromaffin medium in 
centrifuge tubes. 
2. Incubate cells with sensor: Take 1 mL of each cell type from the stock and place 
into separate centrifuge tubes. Centrifuge the tubes for 5 min (speed “1-2” - rpm 
unknown). Cells form a pellet at the bottom of the tube. Remove supernatant 
using pipetter. Add 2 mL DMEM (Dulbecco’s Modified Eagle Medium) solution to 
each tube. Add sensor from a DMSO stock solution so that the final 
concentration is 10 uL. Incubate (37 °C) and shake (250 rpm) for 30 min. 
3. Rinse & plate onto coverslips: Centrifuge 5 min. Remove DMEM. Wash with 2 
mL PBS buffer pumping up and down with a pipetter to break apart clumped 
cells. Centrifuge 5 min. Remove buffer and repeat. Remove supernatant using a 
pipetter. Add DMEM. Use pipetter and pump the cells up and down to 
“homogenize” the solution. Then take 3 mL of the sensor-cell mixture and plate 
onto each 35 mm glass-bottomed, poly-D-lysine-coated dish (Part # P35GC-1.5-
14-C, MatTek Corporation). Incubate the plated cells at 37 °C for 16 hr.  
 
Confocal Fluorescence Imaging: 
 Bond Life Sciences Center, University of Missouri, Columbia, MO 
o A Zeiss LSM 510 META NLO inverted confocal microscope was utilized. 
Excitation was performed using the 488, 514, 543, or 633 nm laser lines. 
The signal was acquired viewing a 2.4 M depth. 
 Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO 
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o An Olympus Optical FluoView FV1000 confocal laser scanning biological 
microscope was utilized. Excitation was performed using the 440 or 488 
nm laser line. 
 
Part V. Synthetic Procedures & Characterization Data 
 
 
 
 
Compound 13. Compound 11 (250.0 mg, 1.072 mmol), p-toluenesulfonyl chloride (224.8 
mg, 1.179 mmol), and Na2CO3 (340.8 mg, 3.215 mmol) were added to a flame-dried 
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round bottom flask and degassed with N2 for 15 minutes.  Degassed H2O/THF (1:20, 15.0 
mL) was added and the mixture stirred at 50 °C for 30 minutes. The mixture was allowed 
to cool to room temperature. 4-Methoxyphenylboronic acid (12) (179.2 mg, 1.179 
mmol) was added and the mixture was allowed to stir at room temperature for 5 
minutes. Palladium chloride (9.5 mg, 0.054 mmol) was added and the mixture stirred at 
50 °C for 6 hours. The mixture was filtered and the solvent removed in vacuo. The 
remaining residue was purified by chromatography (100% CH2Cl2 → 95:5 CH2Cl2/EtOAc) 
to yield compound 13 (172 mg, 47%) as a pale-yellow oil: 1H NMR (500 MHz, CDCl3) δ 
7.40 (dd, 2H, J = 6.0, 1.0), 7.32 (dd, 1H, J = 8.8, 1.0), 7.02 (dd, 2H, J = 7.8, 1.5), 6.57 (d, 
1H, J = 2.0), 6.53 (dd, 1H, J = 9.3, 2.0), 6.00 (d, 1H, J = 1.0), 3.88 (s, 3H), 3.42 (q, 4H, J = 
7.0), 1.21 (t, 6H, J = 7.0); 13C NMR (125 MHz, CDCl3) δ 162.3, 160.5, 156.8, 150.5, 129.8, 
128.5, 127.9, 114.0, 108.4, 108.0, 107.9, 97.8, 55.4, 44.7, 12.4; IR (neat, cm-1) 2970, 
1712, 1614, 1524, 1417, 1246, 1115, 829; HRMS calculated for C20H21NO3Na
+ (M + Na+): 
346.1414. Found: 346.1415. 
 
91 
 
 
92 
 
 
NeuroSensor 521 (Compound 1g).  POCl3 (5.2 mL, 56.1 mmol) was added to DMF (10.8 
mL, 139.5 mmol) at 0 °C in a flame-dried round bottom flask.  The Vilsmeier reagent was 
stirred at ambient temperature for 45 min. The Vilsmeier reagent (5 mL) was added to a 
solution  of compound 13 (171.8 mg, 0.532 mmol) in DMF (1 mL). The solution was 
stirred at ambient temperature for 12 hours. The resulting red solution was poured onto 
cold H2O (100 mL), basified with saturated NaHCO3  (50 mL), and extracted with CH2Cl2 
(100 mL x 3). The combined organic layers were dried over Na2SO4 and the solvent was 
removed in vacuo. The residue was purified by chromatography (80:20 hexanes:EtOAc 
→ 50:50 hexanes/EtOAc) to yield NeuroSensor 521 (46.1 mg, 25%) as a yellow oil: 1H 
NMR (500 MHz, d-acetone) δ 9.80 (s, 1H), 7.27 (dd, 2H, J = 2.0, 6.5), 7.08 (dd, 2H, J = 2.0, 
6.5), 6.99 (d, 1H, J = 9.5), 6.71 (dd, 1H, J = 2.5, 9.5), 6.55 (d, 1H, J = 2.5), 3.89 (s, 3H), 3.56 
(q, 4H, J = 7.0), 1.22 (t, 6H, J = 7.0); 13C NMR (125 MHz, d-acetone) δ 188.0,  161.8, 
161.2, 160.0, 158.7, 153.9, 131.7, 131.0, 126.2, 114.5, 113.2, 110.6, 109.8, 97.5, 55.7, 
45.5, 12.7; IR (neat, cm-1) 2970, 2919, 2846, 1742, 1615, 1495, 1418, 1356, 1248, 1132; 
HRMS calculated for C21H21NO4Na
+ (M + Na+): 374.1363.  Found: 374.1364. 
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General Synthesis for Benzene-Based NS521 Derivatives 
 
 
 
Compound 14 (0.250 g, 0.894 mmol), arylboronic acid (0.983 mmol), bis(dibenzylidene-
acetone)-palladium(0) (0.041 g, 0.045 mmol), 2-dicyclohexylphosphino-2’,6’-
dimethoxybiphenyl (SPhos) (0.055 g, 0.134 mmol), tribasic potassium phosphate (0.381 
g, 1.788 mmol) were added to a flame-dried round bottom flask and degassed with N2 
for 30 minutes. Degassed THF (distilled, 6 mL) was added and the mixture stirred at 60 
°C for 12 hours under N2. The mixture was allowed to cool to room temperature, 
filtered, rinsed with acetone, and the solvent removed in vacuo. The crude residue was 
purified by chromatography (100% CH2Cl2→80:20 CH2Cl2/EtOAc). The material was 
further purified by chromatography (90:10 hexanes/EtOAc→50:50 hexanes/EtOAc) to 
yield the desired compound as a yellow oil.    
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Compound 1b. Yield 64%; 1H NMR (500 MHz, CD2Cl2) δ 9.78 (s, 1H), 7.47-7.55 (m, 3H), 
7.23-7.30 (m, 2H), 6.93 (d, 1H, J = 10.0 Hz), 6.50-6.57 (m, 2H), 3.45 (q, 4H, J = 7.0 Hz), 
1.23 (t, 6H, J = 7.0 Hz); 13C NMR (125 MHz, CD2Cl2)  188.4, 162.0, 159.9, 158.1, 153.4, 
133.7, 131.2, 129.3, 128.8, 128.7, 112.7, 110.2, 109.5, 97.4, 45.6, 12.5; IR (neat, cm-1) 
2974, 1751, 1715, 1683, 1617, 1559, 1504, 1418, 1354; HRMS calculated for C20H19NO3 
(M + Na+): 344.1257. Found: 344.1254. 
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Compound 1a.  Yield 83%; 1H NMR (500 MHz, CDCl3) δ 9.95 (s, 1H), 8.18 (d, 2H, J = 8.0 
Hz), 7.32 (d, 2H, J = 8.5 Hz), 6.84 (d, 1H, J = 9.0 Hz), 6.52 (d, 1H, J = 2.5 Hz), 6.49 (dd, 1H, J 
= 9.0, 2.5 Hz), 4.43 (q, 2H, J = 7.0 Hz), 3.45 (q, 4H, J = 7.5 Hz), 1.43 (t, 3H, J = 7.0 Hz), 1.23 
(t, 6H, J = 7.0 Hz); 13C NMR (125 MHz, CDCl3)  188.0, 166.0, 160.5, 159.7, 157.8, 153.1, 
138.3, 130.9, 130.8, 129.6, 128.1, 111.7, 109.9, 108.8, 97.1, 61.2, 45.2, 14.3, 12.4; IR 
(neat, cm-1) 2978, 1716, 1614, 1556, 1499, 1356, 1270, 1127, 1103, 727; HRMS 
calculated for C23H23NO5 (M + Na
+): 416.1468. Found: 416.1464. 
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Compound 1i. Yield 77%; 1H NMR (500 MHz, CDCl3) δ 9.82 (s, 1H), 7.08 (d, 1H, J = 9.0 
Hz), 7.00 (d, 1H, J = 8.0 Hz), 6.87 (dd, 1H, J = 8.0, 2.0 Hz), 6.80 (d, 1H, J = 1.5 Hz), 6.50-
6.55 (m, 2H), 3.97 (s, 3H), 3.88 (s, 3H), 3.46 (q, 4H, J = 7.0 Hz), 1.25 (t, 6H, J = 7.0 Hz); 13C 
NMR (125 MHz, CDCl3)  188.5, 162.2, 159.4, 157.7, 153.0, 149.8, 148.9, 130.9, 125.0, 
121.6, 112.6, 111.9, 110.9, 109.6, 109.1, 97.1, 56.1, 56.0, 45.2, 12.4; IR (neat, cm-1) 2974, 
1736, 1650, 1615, 1506, 1455, 1377, 1168; HRMS calculated for C22H23NO5 (M + Na
+): 
404.1468. Found: 404.1465. 
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Compound 1k.  Yield 37%; 1H NMR (500 MHz, CDCl3) δ 9.81 (s, 1H), 7.08 (d, 1H, J = 9.0 
Hz), 6.55 (dd, 1H, J = 9.0, 2.5 Hz), 6.52 (d, 1H, J = 2.5 Hz), 6.51 (s, 2H), 3.94 (s, 3H), 3.86 
(s, 6H), 3.46 (q, 4H, J = 7.0 Hz), 1.24 (t, 6H, J = 7.0 Hz); 13C NMR (125 MHz, CDCl3)  188.3, 
162.3, 159.1, 157.7, 153.4, 138.5, 130.8, 128.2, 112.4, 109.7, 108.8, 105.9, 97.0, 61.1, 
56.3, 45.2, 12.4; IR (neat, cm-1) 1748, 1618, 1495, 1417, 1352, 1123; HRMS calculated for 
C23H25NO6 (M + Na
+): 434.1574. Found: 434.1570. 
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Compound 1d.  Yield 36%; 1H NMR (500 MHz, CDCl3) δ 9.88 (s, 1H), 7.36 (d, 2H, J = 8.5 
Hz), 7.20 (d, 2H, J = 8.5 Hz), 7.01 (d, 1H, J = 8.0 Hz), 6.48-6.52 (m, 2H), 3.45 (q, 4H, J = 7.0 
Hz), 2.56 (s, 3H), 1.24 (t, 6H, J = 7.0); 13C NMR (125 MHz, CDCl3)  188.3, 161.3, 159.9, 
157.8, 153.0, 140.5, 130.9, 129.3, 129.0, 125.7, 112.3, 109.6, 109.0, 97.1, 45.2, 15.3, 
12.4; IR (neat, cm-1) 1746, 1714, 1612, 1558, 1507, 1487, 1420, 1353, 1132; HRMS 
calculated for C21H21NO3S (M + Na
+): 390.113435. Found: 390.113229. 
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Compound 1f. Yield 69%; 1H NMR (500 MHz, CDCl3) δ 9.91 (s, 1H), 7.09 (t, 1H, J = 8.5 
Hz), 6.98-7.03 (m, 3H), 6.49-6.55 (m, 2H), 3.98 (s, 3H), 3.46 (q, 4H, J = 7.0 Hz), 1.22 (t, 6H, 
J = 7.0 Hz) ; 13C NMR (125 MHz, CDCl3)  188.2, 160.1, 159.8, 157.8, 153.0, 152.9, 151.0, 
148.4, 148.3, 130.8, 125.5, 125.4, 124.8, 116.6 (C-F, d, J = 20.0 Hz), 113.2, 113.1, 112.2, 
109.8, 109.0, 97.1, 56.3, 45.2, 12.4 ; IR (neat, cm-1) 1747, 1614, 1556, 1520, 1499, 1429, 
1417, 1354, 1270, 1136; HRMS calculated for C21H20FNO4 (M + Na
+): 392.126857. Found: 
392.126718. 
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Compound 1j. Yield 54%; 1H NMR (500 MHz, CDCl3) δ 9.75 (s, 1H), 7.03-7.10 (m, 3H), 
6.91 (d, 1H, J = 8.5 Hz), 6.50 (dd, 1H, J = 8.5, 2.0 Hz), 6.48 (d, 1H, J = 2.0 Hz), 3.89 (s, 3H), 
3.43 (q, 4H, J = 7.0 Hz), 2.25 (s, 3H), 1.21 (t, 6H, J = 7.0 Hz); 13C NMR (125 MHz, CDCl3)  
188.6, 162.8, 159.2, 158.6, 157.6, 152.9, 131.1, 130.9, 127.8, 126.8, 124.0, 112.5, 109.5, 
109.4, 109.0, 96.9, 55.4, 45.1, 16.2, 12.4; IR (neat, cm-1) 1746, 1611, 1511, 1495, 1419, 
1353, 1251, 1137; HRMS calculated for C22H23NO4 (M + Na
+): 388.151929. Found: 
388.151777. 
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Compound 1h.  Yield 67%; 1H NMR (500 MHz, CDCl3) δ 9.72 (s, 1H), 7.98 (d, 1H, J = 8.5 
Hz), 7.94 (dd, 1H, J = 8.5, 1.5 Hz), 7.58 (t, 1H, J = 7.5 Hz), 7.48-7.54 (m, 2H), 7.41 (td, 1H, J 
= 8.0, 1.0 Hz), 7.34 (dd, 1H, J = 7.0, 1.0 Hz), 6.70 (d, 1H, J = 9.0), 6.55 (d, 1H, J = 2.5 Hz), 
6.37 (dd, 1H, J = 9.5, 2.5 Hz), 3.42 (q, 4H, J = 7.0 Hz), 1.21 (t, 6H, J = 7.0 Hz); 13C NMR 
(125 MHz, CDCl3)  188.0, 161.1, 159.7, 153.2, 133.2, 131.1, 131.0, 130.9, 129.3, 128.5, 
127.1, 126.5, 126.0, 125.1, 125.0, 113.3, 109.8, 109.5, 96.9, 45.2, 12.4; IR (neat, cm-1) 
1744, 1716, 1679, 1614, 1552, 1499, 1417, 1352, 1136; HRMS calculated for C24H21NO3 
(M + Na+): 394.141365. Found: 394.141303. 
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Compound 1c. Yield 82%; 1H NMR (500 MHz, CDCl3) δ 9.79 (s, 1H), 7.39 (t, 1H, J = 8.0 
Hz), 7.31 (d, 1H, J = 8.0 Hz), 7.06-7.09 (m, 2H), 6.98 (d, 1H, J = 10.0 Hz), 6.48-6.53 (m, 
2H), 3.43 (q, 4H, J = 7.0 Hz), 2.42 (s, 3H), 1.22 (t, 6H, J = 7.0 Hz); 13C NMR (125 MHz, 
CDCl3)  188.4, 162.6, 159.4, 157.7, 153.0, 138.2, 132.8, 131.0, 129.9, 129.0, 128.3, 
125.6, 112.3, 109.6, 109.0, 97.0, 45.1, 21.4, 12.4; IR (neat, cm-1) 1744, 1712, 1614, 1556, 
1503, 1417, 1352, 1127, 730; HRMS calculated for C21H21NO3 (M + Na
+): 358.141365. 
Found: 358.141274. 
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Compound 1e. Yield 25%; 1H NMR (500 MHz, CDCl3) δ 9.92 (s, 1H), 7.74 (d, 2H, J = 8.5 
Hz), 7.68 (d, 2H, J = 8.0 Hz), 7.50 (t, 2H, J = 7.5 Hz), 7.42 (t, 1H, J = 7.5 Hz), 7.36 (d, 2H, J = 
8.0 Hz), 7.06 (d, 1H, J = 9.5 Hz), 6.51-6.56 (m, 2H), 3.45 (q, 4H, J = 7.5 Hz), 1.26 (t, 6H, J = 
7.5 Hz); 13C NMR (125 MHz, CDCl3)  188.4, 161.7, 159.8, 157.8, 153.1, 142.0, 140.1, 
131.9, 131.0, 129.0, 128.9, 127.8, 127.2, 127.1, 112.4, 109.7, 109.1, 97.1, 45.2, 12.4; IR 
(neat, cm-1) 1745, 1711, 1610, 1558, 1498, 1419, 1352, 1131; HRMS calculated for 
C26H23NO3 (M + Na
+): 420.157015. Found: 420.156830. 
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Compound 1l. Yield 10%. 1H NMR (500 MHz, CDCl3) δ 9.77 (s, 1H), 7.24 (d, 1H, J = 8.0 
Hz), 7.21 (d, 2H, J = 7.0 Hz), 6.79 (d, 2H, J = 9.0 Hz), 6.49-6.54 (m, 2H), 3.45 (q, 4H, J = 7.0 
Hz), 3.07 (s, 6H), 1.23 (t, 6H, J = 7.0 Hz); 13C NMR (125 MHz, CDCl3)  199.9, 163.4, 159.3, 
157.7, 152.7, 151.2, 131.0, 130.9, 119.1, 112.5, 111.3, 109.3, 109.1, 97.1, 45.1, 40.2, 
12.5; IR (neat, cm-1) 1743, 1610, 1558, 1496, 1418, 1355, 1132; HRMS calculated for 
C22H24N2O3Na (M + Na
+): 365.1860. Found: 365.1860. 
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General Synthesis for Suzuki Coupling of Thiophene-Substituted NS521 Derivatives 
 
 
 
Compound 16 (250.0 mg, 1.072 mmol), p-toluenesulfonyl chloride (224.8 mg, 1.179 
mmol), and Na2CO3 (340.8 mg, 3.215 mmol) were added to a flame-dried round bottom 
flask and degassed with N2 for 15 minutes. Degassed H2O/THF (1:20, 15.0 mL) was 
added and the mixture stirred at 50 °C for 30 minutes. The mixture was allowed to cool 
to room temperature. Thiophene or substituted thiopheneboronic acid (1.179 mmol) 
was added to the mixture and was allowed to stir at room temperature for 5 minutes. 
Palladium chloride (9.5 mg, 0.054 mmol) was added and the mixture stirred at 50 °C for 
6 hours. The mixture was filtered and the solvent removed in vacuo. The remaining 
residue was purified by chromatography (100% CH2Cl2→95:5 CH2Cl2/EtOAc). The 
material was further purified by chromatography (90:10 hexanes/EtOAc→50:50 
hexanes/EtOAc) to yield the desired compound as a pale yellow oil.  
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Compound 18d. Yield 22%; 1H NMR (500 MHz, CDCl3) δ 7.75 (d, 1H, J = 9.0 Hz), 7.21 (d, 
1H, J = 3.5 Hz), 6.85 (dd, 1H, J = 2.5, 1.0 Hz), 6.58 (dd, 1H, J = 9.0, 2.5 Hz) 6.56 (d, 1H, J = 
2.5 Hz), 6.11 (s, 1H), 3.43 (q, 4H, J = 7.0 Hz), 2.57 (s, 3H), 1.22 (t, 6H, J = 7.0 Hz); 13C NMR 
(125 MHz, CDCl3)  162.0, 156.8, 150.6, 148.3, 143.0, 134.8, 128.9, 127.6, 126.2, 108.5, 
107.5, 107.1, 98.0, 44.8, 15.4, 12.5; IR (neat, cm-1) 2970, 1712, 1610, 1585, 1409, 1352, 
1107; HRMS calculated for C18H19NO2S (M + Na
+): 336.1029. Found: 336.1026. 
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Compound 18b. Yield 23%; 1H NMR (500 MHz, CDCl3) δ 7.69 (d, 1H, J = 8.5 Hz), 7.51 (dd, 
1H, J = 5.5, 0.5 Hz), 7.39 (dd, 1H, J = 3.5, 0.5 Hz), 7.18-7.21 (m, 1H), 6.55-6.61 (m, 2H), 
6.15 (s, 1H), 3.44 (q, 4H, J = 7.0 Hz), 1.23 (t, 6H, J = 7.0 Hz); 13C NMR (125 MHz, CDCl3)  
161.8, 156.8, 15.7, 148.2, 137.2, 128.6, 127.8, 127.7, 127.6, 108.6, 108.2, 107.1, 98.0, 
44.8, 12.4; IR (neat, cm-1) 3101, 2974, 1704, 1614, 1430, 1405, 1352, 1274, 1107; HRMS 
calculated for C17H17NO2S (M + Na
+): 322.0872. Found: 322.0871. 
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Compound 18a. Yield 26%; 1H NMR (500 MHz, CDCl3) δ 7.64 (d, 1H, J = 9.0 Hz), 7.16 (d, 
1H, J = 4.0 Hz), 7.01 (d, 1H, J = 4.0 Hz), 6.58 (dd, 1H, J = 9.0, 2.5 Hz), 6.55 (d, 1H, J = 2.5 
Hz), 6.07 (s, 1H), 3.43 (q, 4H, J = 7.0 Hz), 1.22 (t, 6H, J = 7.0 Hz); 13C NMR (125 MHz, 
CDCl3)  161.6, 156.8, 150.8, 147.1, 135.6, 132.6, 128.0, 127.2, 126.9, 108.7, 108.1, 
106.7, 98.0, 44.8, 12.4; IR (neat, cm-1) 2974, 1712, 1614, 1585, 1516, 1434, 1352, 1266, 
1103; HRMS calculated for C17H16ClNO2S (M + Na
+): 356.0482. Found: 356.0481. 
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Compound 18c. Yield 42%; 1H NMR (500 MHz, CDCl3) δ 7.73 (d, 1H, J = 9.0 Hz), 7.20 (s, 
1H), 7.09 (s, 1H), 6.60 (dd, 1H, J = 9.0, 3.0 Hz), 6.57 (d, 1H, J = 2.5 Hz), 6.13 (s, 1H), 3.44 
(q, 4H, J = 7.0 Hz), 2.35 (s, 3H), 1.23 (t, 6H, J = 7.0 Hz); 13C NMR (125 MHz, CDCl3)  161.9, 
156.8, 150.7, 148.4, 138.5, 137.0, 130.9, 127.6, 123.3, 108.5, 107.9, 107.2, 98.0, 44.8, 
15.8, 12.5; IR (neat, cm-1) 2921, 1708, 1610, 1584, 1516, 1409, 1352, 1099; HRMS 
calculated for C18H19NO2S (M + Na
+): 336.102871. Found: 336.102867. 
 
125 
 
 
 
126 
 
General Synthesis for Formylation of Thiophene-Substituted NS521 Derivatives 
 
 
 
POCl3 (5.2 mL, 56.1 mmol) was added to DMF (10.8 mL, 139.5 mmol) at 0 °C in a flame-
dried round bottom flask.  The Vilsmeier reagent was stirred at ambient temperature for 
45 min.  The Vilsmeier reagent (5 mL) was added to a solution of 4-thiophene-
substituted-7-diethylaminocoumarin (18a-d) in DMF (1 mL).  The solution was stirred at 
ambient temperature for 12 hours.  The resulting red solution was poured onto cold 
H2O (100 mL), basified with saturated NaHCO3 (50 mL), and extracted with CH2Cl2 (100 
mL x 3).  The combined organic layers were dried over Na2SO4 and the solvent was 
removed in vacuo.  The residue was purified by chromatography (90:10 hexanes:EtOAc 
→ 50:50 hexanes/EtOAc) to yield the desired formylated compound as a yellow oil. 
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Compound 2c.  Yield 72%; 1H NMR (500 MHz, CDCl3) δ 9.89 (s, 1H), 7.34 (d, 1H, J = 8.5 
Hz), 7.19 (s, 1H), 6.97 (s, 1H), 6.57 (dd, 1H, J = 9.0, 2.5 Hz), 6.50 (d, 1H, J = 2.5 Hz), 3.46 
(q, 4H, J = 7.0 Hz), 2.36 (s, 3H), 1.25 (t, 6H, J = 7.0 Hz); 13C NMR (125 MHz, CDCl3)  188.0, 
158.8, 157.5, 155.3, 153.1, 138.1, 132.3, 131.8, 130.6, 124.0, 113.5, 109.7, 109.1, 97.1, 
45.2, 15.6, 12.5; IR (neat, cm-1) 2966, 1748, 1712, 1610, 1438, 1373, 1270, 1070, 731; 
HRMS calculated for C19H19NO3S (M + Na
+): 364.097785. Found: 364.097734. 
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NeuroSensor 539 (Compound 2b).  Yield 54%; 1H NMR (500 MHz, CD2Cl2) δ 9.84 (s, 1H), 
7.64 (dd, 1H, J = 5.0, 1.0 Hz), 7.20-7.25 (m, 2H), 7.16 (dd, 1H, J = 4.0, 1.0 Hz), 6.60 (dd, 
1H, J = 9.0, 2.5 Hz), 6.53 (d, 1H, J = 2.5 Hz), 3.46 (q, 4H, J = 7.5 Hz), 1.23 (t, 6H, J = 7.5 Hz); 
13C NMR (125 MHz, CD2Cl2)  188.0, 159.2, 157.9, 155.0, 153.5, 132.7, 130.9, 130.2, 
128.7, 127.7, 114.0, 110.4, 109.8, 97.5, 45.7, 12.6; IR (neat, cm-1) 2921, 1740, 1614, 
1495, 1442, 1417, 1356; HRMS calculated for C18H17NO3S (M + Na
+): 350.0821. Found: 
350.0818. 
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Compound 2d.  Yield 83%; 1H NMR (500 MHz, CDCl3) δ 9.92 (s, 1H), 7.41 (d, 1H, J = 9.5 
Hz), 6.99 (d, 1H, J = 3.5 Hz), 6.88 (dd, 1H, J = 3.5, 1.0 Hz), 6.58 (dd, 1H, J = 9.0, 2.5 Hz), 
6.52 (d, 1H, J = 2.5 Hz), 3.48 (q, 4H, J = 7.0 Hz), 2.61 (s, 3H), 1.26 (t, 6H, J = 7.0 Hz); 13C 
NMR (125 MHz, CDCl3)  188.1, 158.9, 157.5, 155.2, 153.0, 144.0, 130.7, 130.5, 129.5, 
125.8, 113.5, 109.6, 109.1, 97.1, 45.2, 15.3, 12.5; IR (neat, cm-1) 1744, 1610, 1561, 1499, 
1422, 1266, 1123; HRMS calculated for C19H19NO3S (M + Na
+): 364.0978. Found: 
364.0975. 
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Compound 2a. Yield 78%; 1H NMR (500 MHz, CDCl3) δ 10.00 (s, 1H), 7.30 (d, 1H, J = 9.5 
Hz), 7.02 (d, 1H, J = 4.0 Hz), 6.89 (d, 1H, J = 4.0 Hz), 6.57 (dd, 1H, J = 9.0, 2.5), 6.49 (d, 1H, 
J = 2.5 Hz), 3.47 (q, 4H, J = 7.0 Hz), 1.24 (t, 6H, J = 7.0 Hz); 13C NMR (125 MHz, CDCl3)  
187.7, 159.6, 157.5, 153.2, 152.4, 133.1, 131.1, 130.5, 128.8, 126.4, 113.2, 110.0, 109.1, 
97.1, 45.2, 12.4; IR (neat, cm-1) 2970, 1748, 1717, 1611, 1559, 1499, 1439, 1412; HRMS 
calculated for C18H16ClNO3S (M + Na
+): 384.0432. Found: 384.0432. 
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Compound 2e. Yield 89%; 1H NMR (500 MHz, CDCl3) δ 9.99 (s, 1H), 7.88 (dd, 1H, J = 8.5, 
1.5 Hz), 7.85 (dd, 1H, J = 7.0, 2.0 Hz), 7.40-7.48 (m, 2H), 7.35 (s, 1H), 7.29 (d, 1H, J = 9.0 
Hz), 6.50-6.56 (2H), 3.46 (q, 4H, J = 7.0 Hz), 1.24 (t, 6H, J = 7.0 Hz); 13C NMR (125 MHz, 
CDCl3)  187.7, 159.2, 157.5, 154.3, 153.2, 140.7, 139.2, 132.9, 130.7, 126.1, 125.3, 
125.0, 124.2, 122.2, 113.2, 109.9, 109.0, 97.0, 45.2, 12.4; IR (neat, cm-1) 1742, 1615, 
1491, 1418, 1356, 1268, 1148, 723; HRMS calculated for C22H19NO3S (M + Na
+): 
400.097785. Found: 400.097669. 
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Compound 26. Compound 25 (250.0 mg, 1.136 mmol) was dissolved in 11.3 mL CH2Cl2 
and cooled to 0 °C. Aluminium chloride (605.2 mg, 4.542 mmol) was added and the 
solution stirred for 10 min.  2-Thiophene carbonyl chloride (166.5 mg, 1.136 mmol) was 
then added. The mixture stirred for 5 min at 0 °C then warmed to room temperature 
and stirred for 4 hours while sonicating intermittently. Then 6 M HCl was slowly added 
to the mixture which stirred another 10 min. The crude product was extracted with 
CH2Cl2 (50 mL x 3), the organic layers combined and dried over Na2SO4, and the solvent 
removed in vacuo. After purifying twice by column chromatography (9:1 CH2Cl2/EtOAc 
then 8:2 hexanes/EtOAc), compound 26 was isolated as a red oil (316.2 mg, 1.000 mmol, 
88%): 1H NMR (500 MHz, CDCl3) δ 12.83 (s, 1H), 7.69 (dd, 1H, J = 4.0, 1.0 Hz), 7.61 (dd, 
1H, J = 5.0, 1.0 Hz), 7.14-7.18 (m, 1H), 7.07 (s, 1H), 6.13 (s, 1H), 3.53 (t, 2H, J = 5.0 Hz), 
3.41 (q, 2H, J = 7.0 Hz), 3.24 (q, 2H, J = 7.5 Hz), 3.17 (t, 2H, J = 5.0 Hz), 1.17-1.25 (m, 6H); 
13C NMR (125 MHz, CDCl3)  186.8, 161.1, 144.5, 143.2, 131.6, 131.1, 127.6, 127.3, 
112.1, 108.1, 96.6, 47.8, 45.7, 45.5, 44.9, 10.7, 10.3; IR (neat, cm-1) 3101, 2970, 1618, 
1524, 1409, 1324, 1217, 1119; HRMS calculated for C17H20N2O2SNa
+ (M + Na+): 
339.1138. Found: 339.1135. 
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Compound 27. Compound 26 (72.5 mg, 0.229 mmol), (carbethoxymethylene)triphenyl-
phosphorane (87.9 mg, 0.252 mmol), DMAP (2.8 mg, 0.023 mmol), and 2 mL o-xylene 
were combined in a round bottom flask and heated at 140 °C for 4 h. The solvent was 
boiled off and the remaining crude product was purified via column chromatography 
(8:2 hexanes/EtOAc) to yield compound 27 as an orange oil (51.7 mg, 0.176 mmol, 66%): 
1H NMR (500 MHz, CDCl3) δ 7.52 (dd, 1H, J = 5.0, 1.0 Hz), 7.40 (dd, 1H, J = 3.5, 1.0 Hz), 
7.18-7.21 (m, 1H), 6.93 (s, 1H), 6.51 (s, 1H), 6.17 (s, 1H), 3.51 (t, 2H, J = 5.0 Hz), 3.41 (q, 2 
H, J = 7.5 Hz), 3.24-3.30 (m, 4H), 1.22 (t, 3H, J = 7.5 Hz), 1.17 (t, 3H, J = 7.0 Hz); 13C NMR 
(125 MHz, CDCl3)  162.2, 150.2, 147.9, 140.1, 137.8, 131.9, 128.3, 127.8, 127.7, 108.3, 
107.5, 105.6, 97.0, 47.2, 45.7, 45.5, 45.2, 10.3, 10.0; IR (neat, cm-1) 2966, 1716, 1699, 
1608, 1538, 1418, 1373, 1334; HRMS calculated for C19H20N2O2SNa
+ (M + Na+): 
363.1138. Found: 363.1133. 
 
140 
 
 
 
141 
 
 
NeuroSensor 715. The Vilsmeier reagent was made by combining 10.8 mL DMF and 5.23 
mL POCl3 at 0 °C in a flame-dried round bottom flask. The solution was stirred for 1 h. In 
a separate dry flask, compound 27 (66.0 mg, 0.194 mmol) was dissolved in 2 mL DMF 
and purged with N2. To the starting material was added 0.5 mL of the Vilsmeier reagent 
and the mixture stirred at ambient temperature for 2.5 h. The mixture was poured over 
ice chips (100 g), basified to pH 7 with NaHCO3, and extracted with CH2Cl2 (25 mL x 5). 
The solvent was removed in vacuo without heating and the crude product purified via 
column chromatography (1:1 hexanes/EtOAc  100% EtOAc  100% acetone) to yield 
NeuroSensor 715 as a red oil (35.4 mg, 0.096 mmol, 50%)  : 1H NMR (500 MHz, CDCl3) δ 
9.90 (s, 1H), 7.60 (dd, 1H, J = 5.0, 1.0 Hz), 7.19-7.23 (m, 1H), 7.15 (dd, 1H, J = 3.5, 1.0 Hz), 
6.45 (s, 1H), 6.33 (s, 1H), 3.57 (t, 2H, J = 5.0 Hz), 3.46 (q, 2H, J = 7.5 Hz), 3.22 (t, 2H, J = 
5.0 Hz), 3.13 (q, 2H, J = 7.5 Hz), 1.26 (t, 3H, J = 7.5 Hz), 1.05 (t, 3H, J = 7.5 Hz); 13C NMR 
(125 MHz, CDCl3)  188.2, 159.6, 153.8, 152.4, 143.8, 133.0, 132.4, 129.6, 128.2, 127.3, 
113.1, 109.9, 106.5, 95.8, 47.8, 46.4, 45.4, 44.6, 10.6, 9.6; IR (neat, cm-1) 1728, 1695, 
1675, 1605, 1503, 1426, 1336; HRMS calculated for C20H20N2O3SNa
+ (M + Na+): 
391.0868. Found: 391.1078. 
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